Keith Michael Sullivan
James B. Wyngaarden Distinguished Professor of Medicine
Research areas
Early on, Dr. Sullivan and the team at Fred Hutchinson Cancer Research Center developed a systematic investigative approach for the diagnosis and treatment of chronic graft-versus-host disease (GVHD), the major cause of late morbidity and non-relapse mortality following allogeneic stem cell transplantation (SCT). As a result of this work, it became clear that blood and marrow transplant recipients require systematic long-term follow-up to evaluate and treat late complications of high-dose chemoradiotherapy and SCT.
The program grew into a large multidisciplinary team, resulting in improvement in patient outcome and quality of life. Through the late events project, he also contributed to outcomes research, computer decision support systems, and knowledge engineering for follow-up care. With quality of life as a focus, research pursued the application of SCT to diseases with high morbidity but little immediate mortality. For young patients with advanced, symptomatic sickle cell disease, myeloablative conditioning and SCT from an HLA-identical sibling has led to an 86% long-term survival free of sickle cell disease. For individuals with autoimmune diseases such as multiple sclerosis, scleroderma, and systemic lupus erythematosus, current therapy is often incomplete and significant morbidity from the disease or its treatment is observed.
Recent preclinical and clinical data suggest that high-dose immunosupression and SCT can halt the progression and, in some settings, reverse the course of autoimmune diseases. Since his arrival at Duke University, over 30 centers nationwide are participating in Duke-led phase II and III trials to test the toxicity, efficacy, and quality of life following autologous and allogeneic stem cell transplantation for autoimmune diseases.
These trials will also serve as platforms to study the immune repertoire and mechanistic pathways before and after SCT to gain greater insight into the basic mechanisms of autoimmunity.
A national repository of tissue and cell specimens is also part of these NIH-supported trials to further promote scientific study from these unique patients.
- Late effects of cancer treatment and stem cell transplantation
- Chronic graft-versus-host disease
- Transplantation for sickle cell and autoimmune diseases
- Knowledge engineering
Early on, Dr. Sullivan and the team at Fred Hutchinson Cancer Research Center developed a systematic investigative approach for the diagnosis and treatment of chronic graft-versus-host disease (GVHD), the major cause of late morbidity and non-relapse mortality following allogeneic stem cell transplantation (SCT). As a result of this work, it became clear that blood and marrow transplant recipients require systematic long-term follow-up to evaluate and treat late complications of high-dose chemoradiotherapy and SCT.
The program grew into a large multidisciplinary team, resulting in improvement in patient outcome and quality of life. Through the late events project, he also contributed to outcomes research, computer decision support systems, and knowledge engineering for follow-up care. With quality of life as a focus, research pursued the application of SCT to diseases with high morbidity but little immediate mortality. For young patients with advanced, symptomatic sickle cell disease, myeloablative conditioning and SCT from an HLA-identical sibling has led to an 86% long-term survival free of sickle cell disease. For individuals with autoimmune diseases such as multiple sclerosis, scleroderma, and systemic lupus erythematosus, current therapy is often incomplete and significant morbidity from the disease or its treatment is observed.
Recent preclinical and clinical data suggest that high-dose immunosupression and SCT can halt the progression and, in some settings, reverse the course of autoimmune diseases. Since his arrival at Duke University, over 30 centers nationwide are participating in Duke-led phase II and III trials to test the toxicity, efficacy, and quality of life following autologous and allogeneic stem cell transplantation for autoimmune diseases.
These trials will also serve as platforms to study the immune repertoire and mechanistic pathways before and after SCT to gain greater insight into the basic mechanisms of autoimmunity.
A national repository of tissue and cell specimens is also part of these NIH-supported trials to further promote scientific study from these unique patients.
Current Appointments & Affiliations
- James B. Wyngaarden Distinguished Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 1999
- Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2003
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 1999
Contact Information
- Box 3961 Med Ctr, Durham, NC 27710
- Cellular Therapy Abmt, Box 3961 DUMC, Durham, NC 27705
-
sulli025@mc.duke.edu
(919) 668-1000
- Background
-
Education, Training, & Certifications
- M.D., Indiana University at Indianapolis 1971
-
Previous Appointments & Affiliations
- Professor of Medicine with Tenure, Medicine, Medical Oncology, Medicine 1999 - 2003
- Chief, Division of Medical Oncology and Transplantation, Medicine, Medical Oncology, Medicine 1999 - 2003
-
Leadership & Clinical Positions at Duke
-
Chief, Division of Medical Oncology and Transplantation, 1999-2003
Department of Medicine Operations Committee, 1999-2003
Duke Comprehensive Cancer Center, Scientific Executive Committee, 1999-2004
Vice-Dean's Clinical Research Executive Committee, 1999-2005
Director, Oncology Research Training Program, 1999-2005
Hematology/Oncology Fellowship Training Committee, 1999-2014
Department of Medicine Executive Board, 2003-2007
Duke University Advisory Committee on Distinguished Professorships, 2007-2010
Department of Medicine Appointments, Promotion and Tenure Committee, 2011-2018
Chair, Internal Advisory Committee, T32 Fellowship Program in Transplant Infectious Diseases, 2014 to date
-
Chief, Division of Medical Oncology and Transplantation, 1999-2003
-
Academic Positions Outside Duke
- Medical Directors Executive Committee, Fred Hutchinson Cancer Research Center. 1990 - 1998
- Scientific Affairs Committee, University of Washington. 1986 - 1988
- Medical Director, Outpatient Department, Fred Hutchinson Cancer Research Center. 1985 - 1993
- Recognition
-
In the News
-
JUN 15, 2020 The Rheumatologist, a publication of the American College of Rheumatology -
JAN 15, 2020 -
DEC 1, 2019 Biology of Blood and Marrow Transplantation 2020; 26:216-218 -
JUL 10, 2019 Duke Health News -
JAN 3, 2018 Duke Health News -
SEP 22, 2017 NIH Record -
AUG 8, 1996 New York Times
-
-
Awards & Honors
- Elected Fellow. American Society for Transplantation and Cellular Therapy. 2020
- Lifetime Achievement Award. American Society for Transplantation and Cellular Therapy. 2020
- Distinguished Achievement Award. Kelly Government Solutions. 2019
- David Sackett Trial of the Year Award. Society of Clinical Trials. 2018
- Department of Medicine Teaching Award. Duke Department of Medicine. 2016
- Department of Medicine Teaching Award. Duke Department of Medicine. 2012
- Elected Fellow. American Association for the Advancement of Science. 2003
- Highly Cited Researcher, Clinical Medicine Category. Institute for Scientific Information (ISI). 2002
- Electee. Association of American Physicians. 2001
- Research
-
Selected Grants
- Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTG) awarded by National Institutes of Health 2018 - 2023
- Hematopoietic Stem Cell Transplantation for Young Adults with Sickle Cell Disease awarded by Emory University 2016 - 2021
- Phase II, randomised, observer-blind, placebo-controlled,multicentre study to assess the safety, immunogenicity and efficacy of GSK Bilologicals ' Herpes Zoster HZ/su candidate vaccine to adults aged 18 years and older with haematologic malignancies. awarded by GlaxoSmithKline 2013 - 2017
- Scleroderma Cyclophosphamide or Transplantation (SCOT) Trial-Option 6 awarded by National Institutes of Health 2011 - 2017
- Training Program in Inflammatory and Immunological Diseases awarded by National Institutes of Health 1980 - 2017
- Marrow transplant compared to supportive care in adults with sickle cell disease awarded by Emory University 2015 - 2016
- Marrow transplant compared to supportive care in adults with sickle cell disease awarded by Emory University 2014 - 2016
- 14th Annual Southeastern Fellows Research Skills & Training Workshop awarded by Jazz Pharmaceuticals 2014 - 2015
- Home-Based Tablet Computer Pain Coping Skills Following Stem Cell Transplant awarded by National Institutes of Health 2013 - 2015
- Hematopoietic Cell Therapy for Young Adults with Severe Sickle Cell Disease awarded by University of Pittsburgh 2011 - 2014
- Scleroderma Cyclophosphamide or Transplantation (SCOT) Trial-Option 2 awarded by National Institutes of Health 2012 - 2013
- Scleroderma Cyclophosphamide or Transplantation (SCOT) Trial awarded by National Institutes of Health 2011 - 2012
- National Collaborative Study of Stem Cell Transplantation for Autoimmune Disease awarded by National Institutes of Health 2011
- Same awarded by National Institutes of Health 2000 - 2011
- Immunotherapy with Renal Tumor RNA Transfected Dendritic Cells awarded by National Institutes of Health 2001 - 2005
- Same awarded by National Institutes of Health 1999 - 2000
-
External Relationships
- GlaxoSmithKline
- Jasper
- Kiadis
- Magenta Therapeutics
- Talaris
- Xenikos
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Sullivan, Keith M., Francis A. Farraye, Kevin L. Winthrop, David O. Willer, Peter Vink, and Fernanda Tavares-Da-Silva. “Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions.” Vaccine 41, no. 1 (January 4, 2023): 36–48. https://doi.org/10.1016/j.vaccine.2022.10.063.Full Text Link to Item
-
Ayoglu, Burcu, Michele Donato, Daniel E. Furst, Leslie J. Crofford, Ellen Goldmuntz, Lynette Keyes-Elstein, Judith James, et al. “Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation.” Annals of the Rheumatic Diseases, January 2023, annrheumdis-2021-221926. https://doi.org/10.1136/ard-2021-221926.Full Text
-
Khanna, Dinesh, Nancy Krieger, and Keith M. Sullivan. “Improving outcomes in scleroderma: recent progress of cell-based therapies.” Rheumatology (Oxford), November 10, 2022. https://doi.org/10.1093/rheumatology/keac628.Full Text Link to Item
-
Krishnamurti, Lakshmanan, Donna Neuberg, Keith M. Sullivan, Shannon Smith, Mary Eapen, and Mark C. Walters. “Enrollment Lessons from a Biological Assignment Study of Marrow Transplantation versus Standard Care for Adolescents and Young Adults with Sickle Cell Disease: Considerations for Future Gene and Cellular Therapy Trials.” Transplant Cell Ther, October 18, 2022. https://doi.org/10.1016/j.jtct.2022.10.008.Full Text Link to Item
-
Adamska, Julia Z., Amin Zia, Michelle S. Bloom, Leslie J. Crofford, Daniel E. Furst, Ellen Goldmuntz, Lynette Keyes-Elstein, et al. “Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis.” Ann Rheum Dis, October 14, 2022. https://doi.org/10.1136/ard-2021-221925.Full Text Link to Item
-
Shah, Ankoor, Jan Storek, Rob Woolson, Ashley Pinckney, Lynnette Keyes-Elstein, Paul K. Wallace, Gregory D. Sempowski, et al. “Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy.” Rheumatology (Oxford) 61, no. 10 (October 6, 2022): 4155–62. https://doi.org/10.1093/rheumatology/keac015.Full Text Link to Item
-
Kim, Joon Hyung, Robert Johnson, Martina Kovac, Anthony L. Cunningham, Mohamed Amakrane, Keith M. Sullivan, Alemnew F. Dagnew, Desmond Curran, and Anne Schuind. “Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials.” Pain, August 19, 2022. https://doi.org/10.1097/j.pain.0000000000002760.Full Text Link to Item
-
Stadtmauer, Edward A., Keith M. Sullivan, Mohamed El Idrissi, Bruno Salaun, Aránzazu Alonso Alonso, Charalambos Andreadis, Veli-Jukka Anttila, et al. “Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice.” Hum Vaccin Immunother 17, no. 11 (November 2, 2021): 4144–54. https://doi.org/10.1080/21645515.2021.1953346.Full Text Link to Item
-
Keyes-Elstein, Lynette, Ashley Pinckney, Ellen Goldmuntz, Beverly Welch, Jennifer M. Franks, Viktor Martyanov, Tammara A. Wood, et al. “Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data.” Arthritis Care Res (Hoboken), September 17, 2021. https://doi.org/10.1002/acr.24785.Full Text Link to Item
-
Shah, Ankoor, J. Spierings, J. M. van Laar, and Keith M. Sullivan. “Re-evaluating inclusion criteria for autologous hematopoietic stem cell transplantation in advanced systemic sclerosis: Three successful cases and review of the literature.” J Scleroderma Relat Disord 6, no. 2 (June 2021): 199–205. https://doi.org/10.1177/2397198320985766.Full Text Link to Item
-
Bellocchi, Chiara, Jun Ying, Ellen A. Goldmuntz, Lynette Keyes-Elstein, John Varga, Monique E. Hinchcliff, Marka A. Lyons, et al. “Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis.” Arthritis Rheumatol 73, no. 4 (April 2021): 660–70. https://doi.org/10.1002/art.41570.Full Text Link to Item
-
Cardones, Adela R., Russell P. Hall, Keith M. Sullivan, Joanna Hooten, Seung Yun Lee, Beiyu Liu, Cynthia L. Green, et al. “Quantifying Skin Stiffness in Graft-Versus-Host Disease, Morphea, and Systemic Sclerosis Using Acoustic Radiation Force Impulse Imaging and Shear Wave Elastography.” J Invest Dermatol 141, no. 4 (April 2021): 924-927.e2. https://doi.org/10.1016/j.jid.2020.07.031.Full Text Link to Item
-
Maung, Ko K., Benny J. Chen, Ian Barak, Zhiguo Li, David A. Rizzieri, Cristina Gasparetto, Keith M. Sullivan, et al. “Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation.” Bone Marrow Transplant 56, no. 1 (January 2021): 137–43. https://doi.org/10.1038/s41409-020-0991-5.Full Text Link to Item
-
Sullivan, Keith M., and Lynette Keyes-Elstein. “Cross-trial comparisons in reviews: proceed with caution.” Nat Rev Rheumatol 16, no. 12 (December 2020): 663–64. https://doi.org/10.1038/s41584-020-0492-3.Full Text Link to Item
-
Tay, J., S. Beattie, C. Bredeson, R. Brazauskas, N. He, I. A. Ahmed, M. Aljurf, et al. “Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes.” Curr Oncol 27, no. 6 (December 1, 2020): 596–606. https://doi.org/10.3747/co.27.6327.Full Text Link to Item
-
Franks, Jennifer M., Viktor Martyanov, Yue Wang, Tammara A. Wood, Ashley Pinckney, Leslie J. Crofford, Lynette Keyes-Elstein, et al. “Machine learning predicts stem cell transplant response in severe scleroderma.” Ann Rheum Dis 79, no. 12 (December 2020): 1608–15. https://doi.org/10.1136/annrheumdis-2020-217033.Full Text Link to Item
-
Smith, Patrick, Jillian C. Thompson, Elena Perea, Brian Wasserman, Lauren Bohannon, Alessandro Racioppi, Taewoong Choi, et al. “Clinical and Neuroimaging Correlates of Post-Transplant Delirium.” Biol Blood Marrow Transplant 26, no. 12 (December 2020): 2323–28. https://doi.org/10.1016/j.bbmt.2020.09.016.Full Text Link to Item
-
Tay, J., S. Beattie, C. Bredeson, R. Brazauskas, N. He, I. A. Ahmed, M. Aljurf, et al. “Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes.” Curr Oncol 27, no. 6 (December 2020): e596–606. https://doi.org/10.3747/co.27.6327.Full Text Link to Item
-
Keyes-Elstein, Lynette, Erica Brittain, Ashley Pinckney, Ellen A. Goldmuntz, and Keith M. Sullivan. “Safety and efficacy of HSCT for systemic sclerosis across clinical trials.” Nat Rev Rheumatol 16, no. 11 (November 2020): 661. https://doi.org/10.1038/s41584-020-0493-2.Full Text Link to Item
-
Khanna, Dinesh, Celia J. F. Lin, Daniel E. Furst, Jonathan Goldin, Grace Kim, Masataka Kuwana, Yannick Allanore, et al. “Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.” The Lancet. Respiratory Medicine 8, no. 10 (October 2020): 963–74. https://doi.org/10.1016/s2213-2600(20)30318-0.Full Text
-
Maung, Ko, Sendhilnathan Ramalingam, Mohammad Chaudhry, Yi Ren, Sin-Ho Jung, Kristi Romero, Kelly Corbet, et al. “Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality.” Plos One 15, no. 9 (2020): e0238824. https://doi.org/10.1371/journal.pone.0238824.Full Text Link to Item
-
Sullivan, Keith M., and Stefanie Sarantopoulos. “Allogeneic HSCT for autoimmune disease: a shared decision.” Nat Rev Rheumatol 15, no. 12 (December 2019): 701–2. https://doi.org/10.1038/s41584-019-0306-7.Full Text Link to Item
-
Curran, Desmond, Sean Matthews, Scott D. Rowley, Jo-Anne H. Young, Adriana Bastidas, Achilles Anagnostopoulos, Ibrahim Barista, et al. “Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT).” Biol Blood Marrow Transplant 25, no. 12 (December 2019): 2474–81. https://doi.org/10.1016/j.bbmt.2019.07.036.Full Text Link to Item
-
Ng, Sue-Ann, and Keith M. Sullivan. “Application of stem cell transplantation in autoimmune diseases.” Curr Opin Hematol 26, no. 6 (November 2019): 392–98. https://doi.org/10.1097/MOH.0000000000000531.Full Text Link to Item
-
Assassi, Shervin, Xuan Wang, Guocai Chen, Ellen Goldmuntz, Lynette Keyes-Elstein, Jun Ying, Paul K. Wallace, et al. “Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures.” Ann Rheum Dis 78, no. 10 (October 2019): 1371–78. https://doi.org/10.1136/annrheumdis-2019-215770.Full Text Link to Item
-
Blanchard, S. K., K. M. Sullivan, J. N. Hooten, Z. E. Holcomb, K. Rowe Nichols, M. A. Selim, C. L. Rao, R. P. Hall, N. J. Chao, and A. R. Cardones. “High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease.” Br J Dermatol 181, no. 4 (October 2019): 869–71. https://doi.org/10.1111/bjd.18028.Full Text Link to Item
-
Bastidas, Adriana, Javier de la Serna, Mohamed El Idrissi, Lidia Oostvogels, Philippe Quittet, Javier López-Jiménez, Filiz Vural, et al. “Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.” Jama 322, no. 2 (July 9, 2019): 123–33. https://doi.org/10.1001/jama.2019.9053.Full Text Link to Item
-
Cardones, Adela R., Keith M. Sullivan, Cindy Green, Nelson J. Chao, Krista Rowe-Nichols, Lionel L. Bañez, Claude S. Burton, et al. “Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.” Jama Dermatol 155, no. 7 (July 1, 2019): 833–37. https://doi.org/10.1001/jamadermatol.2018.5459.Full Text Link to Item
-
Cohen, Jeffrey A., Laura E. Baldassari, Harold L. Atkins, James D. Bowen, Christopher Bredeson, Paul A. Carpenter, John R. Corboy, et al. “Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation.” Biol Blood Marrow Transplant 25, no. 5 (May 2019): 845–54. https://doi.org/10.1016/j.bbmt.2019.02.014.Full Text Link to Item
-
Krishnamurti, Lakshmanan, Donna S. Neuberg, Keith M. Sullivan, Naynesh R. Kamani, Allistair Abraham, Federico Campigotto, Wandi Zhang, et al. “Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.” Am J Hematol 94, no. 4 (April 2019): 446–54. https://doi.org/10.1002/ajh.25401.Full Text Link to Item
-
Sarantopoulos, Stefanie, Adela R. Cardones, and Keith M. Sullivan. “How I treat refractory chronic graft-versus-host disease.” Blood 133, no. 11 (March 14, 2019): 1191–1200. https://doi.org/10.1182/blood-2018-04-785899.Full Text Link to Item
-
Volkmann, Elizabeth R., Donald P. Tashkin, Myung Sim, Ning Li, Ellen Goldmuntz, Lynette Keyes-Elstein, Ashley Pinckney, et al. “Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts.” Ann Rheum Dis 78, no. 1 (January 2019): 122–30. https://doi.org/10.1136/annrheumdis-2018-213708.Full Text Link to Item
-
Sullivan, Keith M., Navneet S. Majhail, Christopher Bredeson, Paul A. Carpenter, Soumya Chatterjee, Leslie J. Crofford, George E. Georges, et al. “Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.” Biol Blood Marrow Transplant 24, no. 10 (October 2018): 1961–64. https://doi.org/10.1016/j.bbmt.2018.06.025.Full Text Open Access Copy Link to Item
-
Cardona, Diana M., Claire J. Detweiler, Michael J. Shealy, Anthony D. Sung, Daniel M. Wild, Martin H. Poleski, Bryan L. Balmadrid, Constance T. Cirrincione, David N. Howell, and Keith M. Sullivan. “Use of the National Institutes of Health Consensus Guidelines Improves the Diagnostic Sensitivity of Gastrointestinal Graft-Versus-Host Disease.” Arch Pathol Lab Med 142, no. 9 (September 2018): 1098–1105. https://doi.org/10.5858/arpa.2017-0054-OA.Full Text Link to Item
-
Wood, William A., Ruta Brazauskas, Zhen-Huan Hu, Hisham Abdel-Azim, Ibrahim A. Ahmed, Mahmoud Aljurf, Sherif Badawy, et al. “Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis.” Biol Blood Marrow Transplant 24, no. 9 (September 2018): 1928–35. https://doi.org/10.1016/j.bbmt.2018.03.016.Full Text Link to Item
-
Sullivan, Keith M., Mitchell Horwitz, Ifeyinwa Osunkwo, Nirmish Shah, and John J. Strouse. “Shared Decision-Making in Hematopoietic Stem Cell Transplantation for Sickle Cell Disease.” Biol Blood Marrow Transplant 24, no. 5 (May 2018): 883–84. https://doi.org/10.1016/j.bbmt.2018.04.001.Full Text Link to Item
-
Sung, Anthony D., Syed Hassan, Diana M. Cardona, Daniel Wild, Krista Rowe Nichols, Hossein Mehdikhani, Bryan Balmadrid, et al. “Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults.” Biol Blood Marrow Transplant 24, no. 4 (April 2018): 734–40. https://doi.org/10.1016/j.bbmt.2017.12.772.Full Text Link to Item
-
Somers, Tamara J., Sarah A. Kelleher, Caroline S. Dorfman, Rebecca A. Shelby, Hannah M. Fisher, Krista Rowe Nichols, Keith M. Sullivan, et al. “An mHealth Pain Coping Skills Training Intervention for Hematopoietic Stem Cell Transplantation Patients: Development and Pilot Randomized Controlled Trial.” Jmir Mhealth Uhealth 6, no. 3 (March 19, 2018): e66. https://doi.org/10.2196/mhealth.8565.Full Text Link to Item
-
Sullivan, Keith M., Ellen A. Goldmuntz, and Daniel E. Furst. “Autologous Stem-Cell Transplantation for Severe Scleroderma.” N Engl J Med 378, no. 11 (March 15, 2018): 1066–67. https://doi.org/10.1056/NEJMc1801275.Full Text Link to Item
-
Sullivan, Keith M., Ellen A. Goldmuntz, Lynette Keyes-Elstein, Peter A. McSweeney, Ashley Pinckney, Beverly Welch, Maureen D. Mayes, et al. “Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.” N Engl J Med 378, no. 1 (January 4, 2018): 35–47. https://doi.org/10.1056/nejmoa1703327.Full Text Link to Item
-
Sivaraj, D., W. Bacon, G. D. Long, D. A. Rizzieri, M. E. Horwitz, K. M. Sullivan, Y. Kang, Z. Li, N. J. Chao, and C. Gasparetto. “High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma.” Bone Marrow Transplant 53, no. 1 (January 2018): 34–38. https://doi.org/10.1038/bmt.2017.208.Full Text Link to Item
-
Huang, Li-Wen, Wendi Bacon, Constance Cirrincione, Bercedis Peterson, Gwynn Long, David Rizzieri, Keith M. Sullivan, et al. “Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma.” Hematol Oncol 35, no. 4 (December 2017): 752–59. https://doi.org/10.1002/hon.2379.Full Text Link to Item
-
Arnold, Staci D., Ruta Brazauskas, Naya He, Yimei Li, Richard Aplenc, Zhezhen Jin, Matt Hall, et al. “Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases.” Haematologica 102, no. 11 (November 2017): 1823–32. https://doi.org/10.3324/haematol.2017.169581.Full Text Link to Item
-
Keever-Taylor, Carolyn A., Shelly Heimfeld, Kaitlyn C. Steinmiller, Richard A. Nash, Keith M. Sullivan, Christine W. Czarniecki, Tomeka C. Granderson, Julia S. Goldstein, and Linda M. Griffith. “Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases.” Biol Blood Marrow Transplant 23, no. 9 (September 2017): 1463–72. https://doi.org/10.1016/j.bbmt.2017.05.018.Full Text Link to Item
-
Somers, Tamara J., Sarah A. Kelleher, Caroline S. Dorfman, Rebecca A. Shelby, Hannah M. Fisher, Krista Rowe Nichols, Keith M. Sullivan, et al. “An mHealth Pain Coping Skills Training Intervention for Hematopoietic Stem Cell Transplantation Patients: Development and Pilot Randomized Controlled Trial (Preprint),” July 27, 2017. https://doi.org/10.2196/preprints.8565.Full Text
-
Anand, Sarah, Samantha Thomas, Terry Hyslop, Janet Adcock, Kelly Corbet, Cristina Gasparetto, Richard Lopez, et al. “Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization.” Biol Blood Marrow Transplant 23, no. 7 (July 2017): 1151–57. https://doi.org/10.1016/j.bbmt.2017.04.001.Full Text Link to Item
-
Sivaraj, Dharshan, Michael M. Green, Zhiguo Li, Anthony D. Sung, Stefanie Sarantopoulos, Yubin Kang, Gwynn D. Long, et al. “Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma.” Biol Blood Marrow Transplant 23, no. 2 (February 2017): 262–68. https://doi.org/10.1016/j.bbmt.2016.11.010.Full Text Link to Item
-
Sung, Anthony D., Julia A. M. Sung, Samantha Thomas, Terry Hyslop, Cristina Gasparetto, Gwynn Long, David Rizzieri, et al. “Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial.” Clin Infect Dis 63, no. 8 (October 15, 2016): 999–1006. https://doi.org/10.1093/cid/ciw451.Full Text Link to Item
-
Sullivan, Keith M., Ankoor Shah, Stefanie Sarantopoulos, and Daniel E. Furst. “Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients With Pulmonary Involvement.” Arthritis Rheumatol 68, no. 10 (October 2016): 2361–71. https://doi.org/10.1002/art.39748.Full Text Open Access Copy Link to Item
-
Green, Michael M. B., Nelson Chao, Saurabh Chhabra, Kelly Corbet, Cristina Gasparetto, Ari Horwitz, Zhiguo Li, et al. “Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.” J Hematol Oncol 9, no. 1 (August 17, 2016): 71. https://doi.org/10.1186/s13045-016-0301-2.Full Text Open Access Copy Link to Item
-
Wild, Daniel, Anthony D. Sung, Diana Cardona, Constance Cirricione, Keith Sullivan, Claire Detweiler, Michael Shealy, et al. “The Diagnostic Yield of Site and Symptom-Based Biopsies for Acute Gastrointestinal Graft-Versus-Host Disease: A 5-Year Retrospective Review.” Dig Dis Sci 61, no. 3 (March 2016): 806–13. https://doi.org/10.1007/s10620-015-3938-8.Full Text Link to Item
-
Walters, Mark C., Laura M. De Castro, Keith M. Sullivan, Lakshmanan Krishnamurti, Naynesh Kamani, Christopher Bredeson, Donna Neuberg, et al. “Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.” Biol Blood Marrow Transplant 22, no. 2 (February 2016): 207–11. https://doi.org/10.1016/j.bbmt.2015.10.017.Full Text Link to Item
-
Tuchman, Sascha A., Wendi A. Bacon, Li-Wen Huang, Gwynn Long, David Rizzieri, Mitchell Horwitz, John P. Chute, et al. “Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma.” J Clin Apher 30, no. 3 (June 2015): 176–82. https://doi.org/10.1002/jca.21360.Full Text Link to Item
-
Kelleher, Sarah A., Hannah M. Fisher, Rebecca A. Shelby, Keith M. Sullivan, Amy P. Abernethy, Francis J. Keefe, and Tamara J. Somers. “A HYBRID IN-PERSON AND MHEALTH PAIN COPING SKILLS INTERVENTION FOR STEM CELL TRANSPLANT PATIENTS.” Annals of Behavioral Medicine 49 (April 1, 2015): S216–S216.Link to Item
-
Stadtmauer, Edward A., Keith M. Sullivan, Francisco M. Marty, Sanjeet S. Dadwal, Genovefa A. Papanicolaou, Thomas C. Shea, Sherif B. Mossad, et al. “A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.” Blood 124, no. 19 (November 6, 2014): 2921–29. https://doi.org/10.1182/blood-2014-04-573048.Full Text Link to Item
-
Horwitz, Mitchell E., Nelson J. Chao, David A. Rizzieri, Gwynn D. Long, Keith M. Sullivan, Cristina Gasparetto, John P. Chute, et al. “Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment.” J Clin Invest 124, no. 7 (July 2014): 3121–28. https://doi.org/10.1172/JCI74556.Full Text Open Access Copy Link to Item
-
Kanda, Junya, Gwynn D. Long, Cristina Gasparetto, Mitchell E. Horwitz, Keith M. Sullivan, John P. Chute, Ashley Morris, et al. “Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies.” Biol Blood Marrow Transplant 20, no. 2 (February 2014): 257–63. https://doi.org/10.1016/j.bbmt.2013.11.010.Full Text Link to Item
-
Laar, Jacob M. van, and Keith Sullivan. “Stem cell transplantation in systemic sclerosis.” Curr Opin Rheumatol 25, no. 6 (November 2013): 719–25. https://doi.org/10.1097/01.bor.0000434669.32150.ac.Full Text Link to Item
-
Kanda, J., L. Kaynar, Y. Kanda, V. K. Prasad, S. H. Parikh, L. Lan, T. Shen, et al. “Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment.” Bone Marrow Transplant 48, no. 7 (July 2013): 926–31. https://doi.org/10.1038/bmt.2012.279.Full Text Open Access Copy Link to Item
-
Hung, Emily W., Maureen D. Mayes, Roozbeh Sharif, Shervin Assassi, Victor I. Machicao, Chitra Hosing, E William St Clair, et al. “Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial.” J Rheumatol 40, no. 4 (April 2013): 455–60. https://doi.org/10.3899/jrheum.121087.Full Text Link to Item
-
Spasojevic, Ivan, Ligia R. S. da Costa, Mitchell E. Horwitz, Gwynn D. Long, Keith M. Sullivan, John P. Chute, Cristina Gasparetto, Ashley Morris, Nelson J. Chao, and David A. Rizzieri. “Mini test dose of intravenous busulfan (busulfex(®)) in allogeneic non-myeloablative stem cell transplantation, followed by liquid chromatography tandem-mass spectrometry.” Cancer Invest 30, no. 9 (November 2012): 679–82. https://doi.org/10.3109/07357907.2012.726386.Full Text Link to Item
-
Kanda, Junya, Lun-Wei Chiou, Paul Szabolcs, Gregory D. Sempowski, David A. Rizzieri, Gwynn D. Long, Keith M. Sullivan, et al. “Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.” Biol Blood Marrow Transplant 18, no. 11 (November 2012): 1664-1676.e1. https://doi.org/10.1016/j.bbmt.2012.06.005.Full Text Link to Item
-
Pasquini, Marcelo C., Julio Voltarelli, Harold L. Atkins, Nelson Hamerschlak, Xiaobo Zhong, Kwang Woo Ahn, Keith M. Sullivan, et al. “Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.” Biol Blood Marrow Transplant 18, no. 10 (October 2012): 1471–78. https://doi.org/10.1016/j.bbmt.2012.06.003.Full Text Link to Item
-
Horwitz, M. E., J. P. Chute, C. Gasparetto, G. D. Long, C. McDonald, A. Morris, D. A. Rizzieri, K. M. Sullivan, and N. J. Chao. “Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration.” Bone Marrow Transplant 47, no. 8 (August 2012): 1051–55. https://doi.org/10.1038/bmt.2011.217.Full Text Link to Item
-
Chen, D. -. F., V. K. Prasad, G. Broadwater, N. L. Reinsmoen, A. DeOliveira, A. Clark, K. M. Sullivan, et al. “Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors.” Bone Marrow Transplant 47, no. 6 (June 2012): 817–23. https://doi.org/10.1038/bmt.2011.181.Full Text Link to Item
-
Kanda, J., M. E. Horwitz, G. D. Long, C. Gasparetto, K. M. Sullivan, J. P. Chute, A. Morris, et al. “Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation.” Bone Marrow Transplant 47, no. 5 (May 2012): 700–705. https://doi.org/10.1038/bmt.2011.158.Full Text Link to Item
-
Sullivan, Keith M., Frederick M. Wigley, Christopher P. Denton, Jacob M. van Laar, and Daniel E. Furst. “Haemopoietic stem-cell transplantation for systemic sclerosis.” Lancet 379, no. 9812 (January 21, 2012): 219. https://doi.org/10.1016/S0140-6736(12)60100-7.Full Text Link to Item
-
Burt, R. K., M. Gheorghiade, S. Shah, E. Ruderman, and J. Schroeder. “Haemopoietic stem-cell transplantation for systemic sclerosis - Authors' reply.” The Lancet 379, no. 9812 (January 1, 2012): 219–20. https://doi.org/10.1016/S0140-6736(12)60101-9.Full Text
-
Kanda, Junya, David A. Rizzieri, Cristina Gasparetto, Gwynn D. Long, John P. Chute, Keith M. Sullivan, Ashley Morris, et al. “Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.” Biol Blood Marrow Transplant 17, no. 6 (June 2011): 867–74. https://doi.org/10.1016/j.bbmt.2010.09.009.Full Text Link to Item
-
Palmer, J., T. Goggins, G. Broadwater, N. Chao, M. Horwitz, A. Beaven, K. Sullivan, R. E. Coleman, and D. Rizzieri. “Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma.” Bone Marrow Transplant 46, no. 6 (June 2011): 847–51. https://doi.org/10.1038/bmt.2010.203.Full Text Link to Item
-
Hosing, Chitra, Richard Nash, Peter McSweeney, Shin Mineishi, James Seibold, Linda M. Griffith, Howard Shulman, et al. “Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.” Biol Blood Marrow Transplant 17, no. 5 (May 2011): 674–81. https://doi.org/10.1016/j.bbmt.2010.08.003.Full Text Link to Item
-
Craciunescu, Oana I., Beverly A. Steffey, Chris R. Kelsey, Nicole A. Larrier, Cathy J. Paarz-Largay, Robert G. Prosnitz, Nelson Chao, et al. “Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trial.” Int J Radiat Oncol Biol Phys 79, no. 4 (March 15, 2011): 1248–55. https://doi.org/10.1016/j.ijrobp.2010.05.036.Full Text Link to Item
-
Rizzieri, David A., Christopher Crout, Robert Storms, Jared Golob, Gwynn D. Long, Cristina Gasparetto, Keith M. Sullivan, et al. “Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors.” Cancer Invest 29, no. 1 (January 2011): 56–61. https://doi.org/10.3109/07357907.2010.535055.Full Text Link to Item
-
Rizzieri, David A., Robert Storms, Dong-Feng Chen, Gwynn Long, Yiping Yang, Daniel A. Nikcevich, Cristina Gasparetto, et al. “Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation.” Biol Blood Marrow Transplant 16, no. 8 (August 2010): 1107–14. https://doi.org/10.1016/j.bbmt.2010.02.018.Full Text Link to Item
-
Walters, Mark C., and Keith M. Sullivan. “Stem-cell transplantation for sickle cell disease.” N Engl J Med 362, no. 10 (March 11, 2010): 955–56.Link to Item
-
Walters, Mark C., Karen Hardy, Sandie Edwards, Thomas Adamkiewicz, James Barkovich, Francoise Bernaudin, George R. Buchanan, et al. “Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.” Biol Blood Marrow Transplant 16, no. 2 (February 2010): 263–72. https://doi.org/10.1016/j.bbmt.2009.10.005.Full Text Link to Item
-
Gasparetto, Cristina, Jon P. Gockerman, Louis F. Diehl, Carlos M. de Castro, Joseph O. Moore, Gwynn D. Long, Mitchell E. Horwitz, et al. “"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.” Biol Blood Marrow Transplant 16, no. 1 (January 2010): 70–77. https://doi.org/10.1016/j.bbmt.2009.08.017.Full Text Link to Item
-
Sullivan, Keith M., Paolo Muraro, and Alan Tyndall. “Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States.” Biol Blood Marrow Transplant 16, no. 1 Suppl (January 2010): S48–56. https://doi.org/10.1016/j.bbmt.2009.10.034.Full Text Link to Item
-
Furlong, T., P. Martin, M. E. D. Flowers, F. Carnevale-Schianca, R. Yatscoff, T. Chauncey, F. R. Appelbaum, et al. “Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.” Bone Marrow Transplant 44, no. 11 (December 2009): 739–48. https://doi.org/10.1038/bmt.2009.76.Full Text Link to Item
-
Wang, J., R. A. Nash, B. Chu, V. L. Yarnykh, S. M. Schwartz, K. M. Sullivan, and C. Yuan. “Improvements in digital vasculature observed using micro magnetic resonance angiography after high-dose immunosuppression for severe systemic sclerosis.” Bone Marrow Transplant 44, no. 6 (September 2009): 387–89. https://doi.org/10.1038/bmt.2009.35.Full Text Link to Item
-
Chien, Jason W., and Keith M. Sullivan. “Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility?” Biol Blood Marrow Transplant 15, no. 4 (April 2009): 447–53. https://doi.org/10.1016/j.bbmt.2008.12.509.Full Text Link to Item
-
Chao, N. J., and K. M. Sullivan. “Pharmacologic Prevention of Acute Graft-Versus-Host Disease,” March 5, 2009, 1257–74. https://doi.org/10.1002/9781444303537.ch84.Full Text
-
Rizzieri, D. A., P. Dev, G. D. Long, C. Gasparetto, K. M. Sullivan, Ml Horwitz, J. Chute, and N. J. Chao. “Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors.” Bone Marrow Transplant 43, no. 4 (February 2009): 327–33. https://doi.org/10.1038/bmt.2008.321.Full Text Link to Item
-
Gasparet, Cristina, Jon P. Gockerman, Louis F. Diehl, Carlos De Castro, Joseph Moore, Gwynn D. Long, Mitchell Horwitz, et al. “Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma.” Blood 112, no. 11 (November 16, 2008): 1142–1142.Link to Item
-
Palmer, Jeanne, Timothy Goggins, Gloria Broadwater, Nelson J. Chao, John Chute, R. E. Coleman, Keith M. Sullivan, et al. “Early Pre/Post Fluoro-Deoxyglucose Positive Emission Tomography (PET) Does Not Predict Outcome of Patients Undergoing Hematopoietic Stem Cell Transplantation in Hodgkins Disease and Non-Hodgkins Lymphoma.” Blood 112, no. 11 (November 16, 2008): 760–760.Link to Item
-
Horwitz, Mitchell E., Ashley Morris, Cristina Gasparetto, Keith Sullivan, Gwynn Long, John Chute, David Rizzieri, Jackie McPherson, and Nelson Chao. “Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients.” Biol Blood Marrow Transplant 14, no. 5 (May 2008): 591–94. https://doi.org/10.1016/j.bbmt.2008.02.016.Full Text Link to Item
-
Byrne, B. J., M. Horwitz, G. D. Long, C. Gasparetto, K. M. Sullivan, J. Chute, N. J. Chao, and D. A. Rizzieri. “Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection.” Bone Marrow Transplant 41, no. 1 (January 2008): 39–43. https://doi.org/10.1038/sj.bmt.1705882.Full Text Link to Item
-
Horwitz, Mitchell E., Ivan Spasojevic, Ashley Morris, Marilyn Telen, James Essell, Cristina Gasparetto, Keith Sullivan, et al. “Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics.” Biol Blood Marrow Transplant 13, no. 12 (December 2007): 1422–26. https://doi.org/10.1016/j.bbmt.2007.08.050.Full Text Link to Item
-
Nash, Richard A., Peter A. McSweeney, Leslie J. Crofford, Muneer Abidi, Chien-Shing Chen, J David Godwin, Theodore A. Gooley, et al. “High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.” Blood 110, no. 4 (August 15, 2007): 1388–96. https://doi.org/10.1182/blood-2007-02-072389.Full Text Link to Item
-
Panepinto, Julie A., Mark C. Walters, Jeanette Carreras, Judith Marsh, Christopher N. Bredeson, Robert Peter Gale, Gregory A. Hale, et al. “Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research.” Br J Haematol 137, no. 5 (June 2007): 479–85. https://doi.org/10.1111/j.1365-2141.2007.06592.x.Full Text Link to Item
-
Rizzieri, David A., Liang Piu Koh, Gwynn D. Long, Cristina Gasparetto, Keith M. Sullivan, Mitchell Horwitz, John Chute, et al. “Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.” J Clin Oncol 25, no. 6 (February 20, 2007): 690–97. https://doi.org/10.1200/JCO.2006.07.0953.Full Text Link to Item
-
Eggleston, B., M. Patience, S. Edwards, T. Adamkiewicz, G. R. Buchanan, S. C. Davies, R. Dickerhoff, et al. “Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia.” Br J Haematol 136, no. 4 (February 2007): 673–76. https://doi.org/10.1111/j.1365-2141.2006.06486.x.Full Text Link to Item
-
Storek, Jan, Richard A. Nash, Peter A. McSweeney, Daniel E. Furst, and Keith M. Sullivan. “Normal interleukin-7 (IL7) levels and normal IL7 response to CD4 T lymphopenia in patients with multiple sclerosis and systemic sclerosis.” Clin Immunol 121, no. 1 (October 2006): 118–19. https://doi.org/10.1016/j.clim.2006.05.016.Full Text Link to Item
-
Sullivan, Keith M., Peter A. McSweeney, and Richard A. Nash. “Cyclophosphamide in scleroderma lung disease.” N Engl J Med 355, no. 11 (September 14, 2006): 1173–74.Link to Item
-
Nash, Richard A., Peter A. McSweeney, J Lee Nelson, Mark Wener, George E. Georges, Amelia A. Langston, Howard Shulman, et al. “Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis.” Arthritis Rheum 54, no. 6 (June 2006): 1982–86. https://doi.org/10.1002/art.21908.Full Text Link to Item
-
Horwitz, Mitchell E., and Keith M. Sullivan. “Chronic graft-versus-host disease.” Blood Rev 20, no. 1 (January 2006): 15–27. https://doi.org/10.1016/j.blre.2005.01.007.Full Text Link to Item
-
Griffith, Linda M., Steven Z. Pavletic, Alan Tyndall, Christopher N. Bredeson, James D. Bowen, Richard W. Childs, Alois Gratwohl, et al. “Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.” Biol Blood Marrow Transplant 11, no. 11 (November 2005): 862–70. https://doi.org/10.1016/j.bbmt.2005.07.009.Full Text Link to Item
-
Furst, Daniel E., Richard Nash, Keith M. Sullivan, Riccardo Saccardi, and Peter McSweeney. “High dose immunotherapy with stem cell rescue in severe systemic sclerosis: an idea that is moving forward.” J Rheumatol 31, no. 12 (December 2004): 2331–35.Link to Item
-
Storek, Jan, Zhao Zhao, Eugene Lin, Thomas Berger, Peter A. McSweeney, Richard A. Nash, Yoshiki Akatsuka, et al. “Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases).” Clin Immunol 113, no. 3 (December 2004): 285–98. https://doi.org/10.1016/j.clim.2004.07.006.Full Text Link to Item
-
Chao, Nelson J., Liang-Piu Koh, Gwynn D. Long, Cristina Gasparetto, Mitchell Horwitz, Ashley Morris, Martha Lassiter, Keith M. Sullivan, and David A. Rizzieri. “Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens.” Biol Blood Marrow Transplant 10, no. 8 (August 2004): 569–75. https://doi.org/10.1016/j.bbmt.2004.05.001.Full Text Link to Item
-
Wang, P. P., and K. M. Sullivan. “Medical expert systems.” Information Sciences 162, no. 2 (May 17, 2004): 63–64. https://doi.org/10.1016/j.ins.2004.03.001.Full Text
-
Nishimura, Jun-Ichi, Yuzuru Kanakura, Russell E. Ware, Tsutomu Shichishima, Hideki Nakakuma, Haruhiko Ninomiya, Carlos M. Decastro, et al. “Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan.” Medicine (Baltimore) 83, no. 3 (May 2004): 193–207. https://doi.org/10.1097/01.md.0000126763.68170.46.Full Text Link to Item
-
Bichindaritz, I., C. Moinpour, E. Kansu, G. Donaldson, N. Bush, and K. M. Sullivan. “Case based reasoning for medical decision-support in a safety critical environment.” Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 2780 LNAI (December 1, 2003): 314–23. https://doi.org/10.1007/978-3-540-39907-0_43.Full Text
-
Nash, Richard A., James D. Bowen, Peter A. McSweeney, Steven Z. Pavletic, Kenneth R. Maravilla, Man-soo Park, Jan Storek, et al. “High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.” Blood 102, no. 7 (October 1, 2003): 2364–72. https://doi.org/10.1182/blood-2002-12-3908.Full Text Link to Item
-
Adamkiewicz, Thomas V., Sharada Sarnaik, George R. Buchanan, Rathi V. Iyer, Scott T. Miller, Charles H. Pegelow, Zora R. Rogers, et al. “Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination.” J Pediatr 143, no. 4 (October 2003): 438–44. https://doi.org/10.1067/S0022-3476(03)00331-7.Full Text Link to Item
-
Chen, Chien-Shing, M. Boeckh, K. Seidel, J. G. Clark, E. Kansu, D. K. Madtes, J. L. Wagner, et al. “Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation.” Bone Marrow Transplant 32, no. 5 (September 2003): 515–22. https://doi.org/10.1038/sj.bmt.1704162.Full Text Link to Item
-
Nash, Richard A., Roger Dansey, Jan Storek, George E. Georges, James D. Bowen, Leona A. Holmberg, George H. Kraft, et al. “Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.” Biol Blood Marrow Transplant 9, no. 9 (September 2003): 583–91. https://doi.org/10.1016/s1083-8791(03)00228-3.Full Text Link to Item
-
Iannone, Robert, James F. Casella, Ephraim J. Fuchs, Allen R. Chen, Richard J. Jones, Ann Woolfrey, Michael Amylon, Keith M. Sullivan, Rainer F. Storb, and Mark C. Walters. “Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia.” Biol Blood Marrow Transplant 9, no. 8 (August 2003): 519–28. https://doi.org/10.1016/s1083-8791(03)00192-7.Full Text Link to Item
-
Kansu, E., Y. Koç, and K. M. Sullivan. “Chronic graft-versus-host disease after allogeneic stem cell transplantation.” Turkish Journal of Cancer 33, no. 1 (January 1, 2003): 9–22.
-
Stevens, A. M., K. M. Sullivan, and J. L. Nelson. “Polymyositis as a manifestation of chronic graft-versus-host disease.” Rheumatology (Oxford) 42, no. 1 (January 2003): 34–39. https://doi.org/10.1093/rheumatology/keg025.Full Text Link to Item
-
McSweeney, Peter A., Richard A. Nash, Keith M. Sullivan, Jan Storek, Leslie J. Crofford, Roger Dansey, Maureen D. Mayes, et al. “High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.” Blood 100, no. 5 (September 1, 2002): 1602–10.Link to Item
-
Sullivan, Keith M. “Bone marrow transplantation for non-malignant disease.” Int J Hematol 76 Suppl 1 (August 2002): 169–70. https://doi.org/10.1007/BF03165239.Full Text Link to Item
-
Goerner, Martin, Theodore Gooley, Mary E. D. Flowers, Keith M. Sullivan, Hans-Peter Kiem, Jean E. Sanders, Paul J. Martin, and Rainer Storb. “Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias.” Biol Blood Marrow Transplant 8, no. 1 (2002): 47–56. https://doi.org/10.1053/bbmt.2002.v8.pm11858190.Full Text Link to Item
-
Benito, A. I., T. Furlong, P. J. Martin, C. Anasetti, F. R. Appelbaum, K. Doney, R. A. Nash, et al. “Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease.” Transplantation 72, no. 12 (December 27, 2001): 1924–29. https://doi.org/10.1097/00007890-200112270-00010.Full Text Link to Item
-
Storek, J., A. Joseph, G. Espino, M. A. Dawson, D. C. Douek, K. M. Sullivan, M. E. Flowers, et al. “Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation.” Blood 98, no. 13 (December 15, 2001): 3505–12. https://doi.org/10.1182/blood.v98.13.3505.Full Text Link to Item
-
Socié, G., R. A. Clift, D. Blaise, A. Devergie, O. Ringden, P. J. Martin, M. Remberger, et al. “Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies.” Blood 98, no. 13 (December 15, 2001): 3569–74. https://doi.org/10.1182/blood.v98.13.3569.Full Text Link to Item
-
McSweeney, P. A., R. A. Nash, K. M. Sullivan, L. J. Crofford, K. T. McDonagh, R. Dansey, M. Mayes, et al. “High-dose immunosuppressive therapy (HDIT) for severe systemic sclerosis (SSc).” Blood 98, no. 11 (November 16, 2001): 395B-395B.Link to Item
-
Nash, R. A., J. D. Bowen, P. A. McSweeney, K. M. Sullivan, Z. S. Pavletic, K. R. Maravilla, J. Al-Omaishi, et al. “Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT).” Blood 98, no. 11 (November 16, 2001): 687A-687A.Link to Item
-
Nishimura, J., Y. Kanakura, R. E. Ware, T. Shichishima, H. Nakakuma, H. Ninomiya, C. M. DeCastro, et al. “Flow cytometric analysis in two large cohorts of patients with PNH.” Blood 98, no. 11 (November 16, 2001): 221A-221A.Link to Item
-
Nishimura, J., Y. Kanakura, R. E. Ware, T. Shichishima, H. Nakakuma, H. Ninomiya, C. M. DeCastro, et al. “The clinical course of PNH in the USA and in Japan.” Blood 98, no. 11 (November 16, 2001): 220A-220A.Link to Item
-
Walters, M. C., A. Woolfrey, B. Torok-Storb, J. M. Zaucha, M. T. Little, E. Trachtenberg, K. M. Sullivan, and R. Storb. “Enrichment of donor erythroid cells after non-myeloablative bone marrow transplantation (BMT) for sickle cell anemia (SCA).” Blood 98, no. 11 (November 16, 2001): 490A-490A.Link to Item
-
Binks, M., J. R. Passweg, D. Furst, P. McSweeney, K. Sullivan, C. Besenthal, J. Finke, et al. “Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.” Ann Rheum Dis 60, no. 6 (June 2001): 577–84. https://doi.org/10.1136/ard.60.6.577.Full Text Link to Item
-
Stern, J. M., K. M. Sullivan, S. M. Ott, K. Seidel, J. C. Fink, G. Longton, and D. J. Sherrard. “Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study.” Biol Blood Marrow Transplant 7, no. 5 (2001): 257–64. https://doi.org/10.1053/bbmt.2001.v7.pm11400947.Full Text Link to Item
-
Sullivan, K. M., C. A. Dykewicz, D. L. Longworth, M. Boeckh, L. R. Baden, R. H. Rubin, K. A. Sepkowitz, K. A. Centers for Disease Control and Prevention, K. A. Infectious Diseases Society of America, and K. A. American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. “Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond.” Hematology Am Soc Hematol Educ Program, 2001, 392–421. https://doi.org/10.1182/asheducation-2001.1.392.Full Text Link to Item
-
Bruno, B., T. Gooley, K. M. Sullivan, C. Davis, W. I. Bensinger, R. Storb, and R. A. Nash. “Secondary failure of platelet recovery after hematopoietic stem cell transplantation.” Biol Blood Marrow Transplant 7, no. 3 (2001): 154–62. https://doi.org/10.1053/bbmt.2001.v7.pm11302549.Full Text Link to Item
-
Walters, M. C., M. Patience, W. Leisenring, Z. R. Rogers, V. M. Aquino, G. R. Buchanan, I. A. Roberts, et al. “Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia.” Biol Blood Marrow Transplant 7, no. 12 (2001): 665–73. https://doi.org/10.1053/bbmt.2001.v7.pm11787529.Full Text Link to Item
-
Naidu, K. D., K. M. Sullivan, P. P. Wang, and Y. Yang. “Managing Personnel through Staff Scheduling Algorithms.” Proceedings of the Joint Conference on Information Sciences 5, no. 2 (December 1, 2000): 829–35.
-
Wang, P. P., K. M. Sullivan, K. D. Naidu, and Y. Yang. “Research on Medical Informatics and Telemedicine.” Proceedings of the Joint Conference on Information Sciences 5, no. 2 (December 1, 2000): 827–28.
-
Yang, Y., K. M. Sullivan, P. P. Wang, and K. D. Naidu. “Applications of Computer Simulation in Medical Scheduling.” Proceedings of the Joint Conference on Information Sciences 5, no. 2 (December 1, 2000): 836–41.
-
McSweeney, P. A., D. E. Furst, R. A. Nash, L. Holmberg, K. McDonagh, L. Crofford, R. Dansey, et al. “High-dose immunosuppressive therapy (HDIT) and autologous stem cell transplant for severe systemic sclerosis (SSc).” Blood 96, no. 11 (November 16, 2000): 844A-844A.Link to Item
-
Nash, R. A., G. H. Kraft, J. D. Bowen, P. A. McSweeney, S. Pavletic, J. Al-Omaishi, J. R. Corboy, et al. “Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT).” Blood 96, no. 11 (November 16, 2000): 842A-843A.Link to Item
-
Nash, R. A., R. Dansey, J. Storek, K. M. Sullivan, S. Pavletic, K. T. McDonagh, G. H. Kraft, et al. “Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD) after high-dose immunosuppressive therapy (HDIT) and autologous CD34-selected stem cell transplantation (SCT) for severe autoimmune diseases.” Blood 96, no. 11 (November 16, 2000): 406A-406A.Link to Item
-
Furlong, T., R. Storb, C. Anasetti, F. R. Appelbaum, H. J. Deeg, K. Doney, P. Martin, K. Sullivan, R. Witherspoon, and R. A. Nash. “Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.” Bone Marrow Transplant 26, no. 9 (November 2000): 985–91. https://doi.org/10.1038/sj.bmt.1702639.Full Text Link to Item
-
Stern, J. M., B. Bruemmer, C. M. Moinpour, K. M. Sullivan, P. Lenssen, and S. N. Aker. “Impact of a randomized, controlled trial of liberal vs conservative hospital discharge criteria on energy, protein, and fluid intake in patients who received marrow transplants.” J Am Diet Assoc 100, no. 9 (September 2000): 1015–22. https://doi.org/10.1016/s0002-8223(00)00299-6.Full Text Link to Item
-
Walters, M. C., R. Storb, M. Patience, W. Leisenring, T. Taylor, J. E. Sanders, G. E. Buchanan, et al. “Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease.” Blood 95, no. 6 (March 15, 2000): 1918–24.Link to Item
-
Walters, M. C., R. Storb, M. Patience, W. Leisenring, T. Taylor, J. E. Sanders, G. E. Buchanan, et al. “Impact of bone marrow transplantation for symptomatic sickle cell disease: An interim report.” Blood 95, no. 6 (March 15, 2000): 1918–24.
-
Bush, N. E., G. W. Donaldson, M. H. Haberman, R. Dacanay, and K. M. Sullivan. “Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients.” Biol Blood Marrow Transplant 6, no. 5A (2000): 576–91. https://doi.org/10.1016/s1083-8791(00)70067-x.Full Text Link to Item
-
Carnevale-Schianca, F., P. Martin, K. Sullivan, M. Flowers, T. Gooley, C. Anasetti, J. Deeg, et al. “Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease.” Biol Blood Marrow Transplant 6, no. 6 (2000): 613–20. https://doi.org/10.1016/s1083-8791(00)70026-7.Full Text Link to Item
-
Kansu, E., and K. M. Sullivan. “Late effects of hematopoietic stem cell transplantation.” Hematology 5, no. 3 (January 1, 2000): 209–22. https://doi.org/10.1080/10245332.2000.11746510.Full Text
-
Sullivan, Keith M., Robertson Parkman, and Mark C. Walters. “Bone Marrow Transplantation for Non-Malignant Disease.” Hematology Am Soc Hematol Educ Program, 2000, 319–38. https://doi.org/10.1182/asheducation-2000.1.319.Full Text Link to Item
-
Socié, G., R. E. Curtis, H. J. Deeg, K. A. Sobocinski, A. H. Filipovich, L. B. Travis, K. M. Sullivan, et al. “New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.” J Clin Oncol 18, no. 2 (January 2000): 348–57. https://doi.org/10.1200/JCO.2000.18.2.348.Full Text Link to Item
-
Donaldson, G. W., C. M. Moinpour, N. E. Bush, M. Chapko, J. Jocom, M. Siadak, M. Nielsen-Stoeck, J. M. Bradshaw, I. Bichindaritz, and K. M. Sullivan. “Physician participation in research surveys. A randomized study of inducements to return mailed research questionnaires.” Eval Health Prof 22, no. 4 (December 1999): 427–41. https://doi.org/10.1177/01632789922034392.Full Text Link to Item
-
Koc, S., W. Leisenring, M. E. Flowers, K. M. Sullivan, and P. J. Martin. “Evaluation of thalidomide for the treatment of chronic graft-versus-host disease in "high risk" patients.” Blood 94, no. 10 (November 15, 1999): 158A-158A.Link to Item
-
Walters, M. C., R. Storb, M. Patience, Z. R. Rogers, G. R. Buchanan, I. Roberts, A. Ogden, et al. “Stable mixed chimerism after bone marrow transplantation (BMT) for Sickle Cell Disease (SCD).” Blood 94, no. 10 (November 15, 1999): 645A-645A.Link to Item
-
Curtis, R. E., L. B. Travis, P. A. Rowlings, G. Socié, D. W. Kingma, P. M. Banks, E. S. Jaffe, et al. “Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.” Blood 94, no. 7 (October 1, 1999): 2208–16.Link to Item
-
Flowers, M. E., E. Kansu, and K. M. Sullivan. “Pathophysiology and treatment of graft-versus-host disease.” Hematol Oncol Clin North Am 13, no. 5 (October 1999): 1091–ix. https://doi.org/10.1016/s0889-8588(05)70111-8.Full Text Link to Item
-
Tyndall, A., A. Fassas, J. Passweg, C. Ruiz de Elvira, M. Attal, P. Brooks, C. Black, et al. “Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease.” Bone Marrow Transplant 24, no. 7 (October 1999): 729–34. https://doi.org/10.1038/sj.bmt.1701987.Full Text Link to Item
-
Strasser, S. I., D. Myerson, C. L. Spurgeon, K. M. Sullivan, B. Storer, H. G. Schoch, S. Kim, M. E. Flowers, and G. B. McDonald. “Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up.” Hepatology 29, no. 6 (June 1999): 1893–99. https://doi.org/10.1002/hep.510290609.Full Text Link to Item
-
Strasser, S. I., K. M. Sullivan, D. Myerson, C. L. Spurgeon, B. Storer, H. G. Schoch, C. S. Murakami, and G. B. McDonald. “Cirrhosis of the liver in long-term marrow transplant survivors.” Blood 93, no. 10 (May 15, 1999): 3259–66.Link to Item
-
Bichindaritz, I., M. F. Siadak, J. Jocom, C. Moinpour, G. Donaldson, N. Bush, M. Chapko, and K. M. Sullivan. “Secure JAVA applets and applications: Guidelines and lessons learnt from the JAVA security model.” Journal of the American Medical Informatics Association, January 1, 1999, 1028–1028.Link to Item
-
Feinstein, L. C., K. Seidel, J. Jocum, R. A. Bowden, C. Anasetti, H. J. Deeg, M. E. Flowers, et al. “Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts.” Biol Blood Marrow Transplant 5, no. 6 (1999): 369–78. https://doi.org/10.1016/s1083-8791(99)70013-3.Full Text Link to Item
-
Clift, R. A., C. D. Buckner, F. R. Appelbaum, K. M. Sullivan, R. Storb, and E. D. Thomas. “Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia.” Blood 92, no. 4 (August 15, 1998): 1455–56.Link to Item
-
Morton, A. J., T. Gooley, J. A. Hansen, F. R. Appelbaum, B. Bruemmer, J. W. Bjerke, R. Clift, et al. “Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase.” Blood 92, no. 2 (July 15, 1998): 394–401.Link to Item
-
Wagner, J. L., M. E. Flowers, G. Longton, R. Storb, M. Schubert, and K. M. Sullivan. “The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation.” Bone Marrow Transplant 22, no. 2 (July 1998): 139–46. https://doi.org/10.1038/sj.bmt.1701313.Full Text Link to Item
-
Sullivan, K. M., C. Anasetti, M. Horowitz, P. A. Rowlings, E. W. Petersdorf, P. J. Martin, R. A. Clift, et al. “Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry.” Ann N Y Acad Sci 850 (June 30, 1998): 312–24. https://doi.org/10.1111/j.1749-6632.1998.tb10488.x.Full Text Link to Item
-
Storb, R., C. Yu, H. J. Deeg, G. Georges, H. P. Kiem, P. A. Mcsweeney, R. A. Nash, et al. “Current and future preparative regimens for bone marrow transplantation in thalassemia.” Ann N Y Acad Sci 850 (June 30, 1998): 276–87. https://doi.org/10.1111/j.1749-6632.1998.tb10484.x.Full Text Link to Item
-
Deeg, H. J., K. Seidel, and K. M. Sullivan. “Body weight and outcome of hematopoietic stem cell transplantation.” Am J Med 104, no. 6 (June 1998): 607–8. https://doi.org/10.1016/s0002-9343(98)00217-4.Full Text Link to Item
-
Deeg, H. J., W. Leisenring, R. Storb, J. Nims, M. E. Flowers, R. P. Witherspoon, J. Sanders, and K. M. Sullivan. “Long-term outcome after marrow transplantation for severe aplastic anemia.” Blood 91, no. 10 (May 15, 1998): 3637–45.Link to Item
-
Hansen, J. A., T. A. Gooley, P. J. Martin, F. Appelbaum, T. R. Chauncey, R. A. Clift, E. W. Petersdorf, et al. “Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.” N Engl J Med 338, no. 14 (April 2, 1998): 962–68. https://doi.org/10.1056/NEJM199804023381405.Full Text Link to Item
-
Lopez-Cubero, S. O., K. M. Sullivan, and G. B. McDonald. “Course of Crohn's disease after allogeneic marrow transplantation.” Gastroenterology 114, no. 3 (March 1998): 433–40. https://doi.org/10.1016/s0016-5085(98)70525-6.Full Text Link to Item
-
Bichindaritz, I., M. F. Siadak, J. Jocom, C. Moinpour, E. Kansu, G. Donaldson, N. Bush, M. Chapko, J. M. Bradshaw, and K. M. Sullivan. “CARE-PARTNER: a computerized knowledge-support system for stem-cell post-transplant long-term follow-up on the World-Wide-Web.” Proc Amia Symp, 1998, 386–90.Link to Item
-
Sullivan, K. M., E. Kansu, B. Storer, J. Jocom, G. Emerson, T. Reagan, V. Emerson, et al. “Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.” Biol Blood Marrow Transplant 4, no. 1 (1998): 20–26. https://doi.org/10.1016/s1083-8791(98)90006-4.Full Text Link to Item
-
Fink, J. C., W. M. Leisenring, K. M. Sullivan, D. J. Sherrard, and N. S. Weiss. “Avascular necrosis following bone marrow transplantation: a case-control study.” Bone 22, no. 1 (January 1998): 67–71. https://doi.org/10.1016/s8756-3282(97)00219-6.Full Text Link to Item
-
Storek, J., T. Gooley, M. Siadak, W. I. Bensinger, D. G. Maloney, T. R. Chauncey, M. Flowers, et al. “Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease.” Blood 90, no. 12 (December 15, 1997): 4705–9.Link to Item
-
Bichindaritz, I., J. M. Bradshaw, and K. M. Sullivan. “Distributed Reuse of Knowledge in a Computerized Decision Support System for Bone-Marrow Post-Transplant Care over the World-Wide Web.” Journal of the American Medical Informatics Association 4, no. SUPPL. (December 1, 1997): 844.
-
Chen, C. S., K. Seidel, J. O. Armitage, J. W. Fay, F. R. Appelbaum, M. M. Horowitz, E. J. Shpall, et al. “Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation.” Biol Blood Marrow Transplant 3, no. 6 (December 1997): 331–40.Link to Item
-
Walters, M. C., M. Patience, W. Leisenring, Z. R. Rogers, P. Dinndorf, S. C. Davies, I. A. Roberts, et al. “Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions.” Biol Blood Marrow Transplant 3, no. 6 (December 1997): 310–15.Link to Item
-
Storb, R., W. Leisenring, C. Anasetti, F. R. Appelbaum, H. J. Deeg, K. Doney, P. Martin, et al. “Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?” Biol Blood Marrow Transplant 3, no. 4 (October 1997): 194–201.Link to Item
-
Sierra, J., J. Radich, J. A. Hansen, P. J. Martin, E. W. Petersdorf, J. Bjerke, E. Bryant, et al. “Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.” Blood 90, no. 4 (August 15, 1997): 1410–14.Link to Item
-
Shpall, E. J. “Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket no. 97N-0068). FAHCT Board of Directors.” J Hematother 6, no. 4 (August 1997): 287–89. https://doi.org/10.1089/scd.1.1997.6.287.Full Text Link to Item
-
Sierra, J., B. Storer, J. A. Hansen, J. W. Bjerke, P. J. Martin, E. W. Petersdorf, F. R. Appelbaum, et al. “Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose.” Blood 89, no. 11 (June 1, 1997): 4226–35.Link to Item
-
Deeg, H. J., D. Lin, W. Leisenring, M. Boeckh, C. Anasetti, F. R. Appelbaum, T. R. Chauncey, et al. “Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.” Blood 89, no. 10 (May 15, 1997): 3880–87.Link to Item
-
Storb, R., W. Leisenring, C. Anasetti, F. R. Appelbaum, C. D. Buckner, W. I. Bensinger, T. Chauncey, et al. “Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin.” Blood 89, no. 10 (May 15, 1997): 3890–91.Link to Item
-
McSweeney, P. A., R. A. Nash, R. Storb, D. E. Furst, J. Gauthier, and K. M. Sullivan. “Autologous stem cell transplantation for autoimmune diseases: issues in protocol development.” J Rheumatol Suppl 48 (May 1997): 79–84.Link to Item
-
Nash, R. A., P. A. McSweeney, R. Storb, J. L. Nelson, J. Gauthier, D. E. Furst, and K. M. Sullivan. “Development of a protocol for allogeneic marrow transplantation for severe systemic sclerosis: paradigm for autoimmune disease.” J Rheumatol Suppl 48 (May 1997): 72–78.Link to Item
-
Nelson, J. L., R. Torrez, F. M. Louie, O. S. Choe, R. Storb, and K. M. Sullivan. “Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation.” J Rheumatol Suppl 48 (May 1997): 23–29.Link to Item
-
Sullivan, K. M. “Longterm followup and quality of life after hematopoietic stem cell transplantation.” J Rheumatol Suppl 48 (May 1997): 46–52.Link to Item
-
Sullivan, K. M., and D. E. Furst. “The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases.” J Rheumatol Suppl 48 (May 1997): 1–4.Link to Item
-
Slattery, J. T., R. A. Clift, C. D. Buckner, J. Radich, B. Storer, W. I. Bensinger, E. Soll, et al. “Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.” Blood 89, no. 8 (April 15, 1997): 3055–60.Link to Item
-
Sullivan, K. M., M. C. Walters, M. Patience, W. Leisenring, G. R. Buchanan, O. Castro, S. C. Davies, et al. “Collaborative study of marrow transplantation for sickle cell disease: Aspects specific for transplantation of hemoglobin disorders.” Bone Marrow Transplantation 19, no. SUPPL. 2 (March 1, 1997): 102–5.
-
Thurston, G. M., D. L. Hayden, P. Burrows, J. I. Clark, V. G. Taret, J. Kandel, M. Courogen, et al. “Quasielastic light scattering study of the living human lens as a function of age.” Curr Eye Res 16, no. 3 (March 1997): 197–207. https://doi.org/10.1076/ceyr.16.3.197.15410.Full Text Link to Item
-
Storek, J., T. Gooley, R. P. Witherspoon, K. M. Sullivan, and R. Storb. “Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts.” Am J Hematol 54, no. 2 (February 1997): 131–38. https://doi.org/10.1002/(sici)1096-8652(199702)54:2<131::aid-ajh6>3.0.co;2-y.Full Text Link to Item
-
Charuhas, P. M., K. L. Fosberg, B. Bruemmer, S. N. Aker, W. Leisenring, K. Seidel, and K. M. Sullivan. “A double-blind randomized trial comparing outpatient parenteral nutrition with intravenous hydration: effect on resumption of oral intake after marrow transplantation.” Jpen J Parenter Enteral Nutr 21, no. 3 (1997): 157–61. https://doi.org/10.1177/0148607197021003157.Full Text Link to Item
-
Rehman, K. L. “Bone marrow transplantation for sickle cell disease.” N Engl J Med 335, no. 24 (December 12, 1996): 1845–46. https://doi.org/10.1056/NEJM199612123352415.Full Text Link to Item
-
Nash, R. A., L. A. Piñeiro, R. Storb, H. J. Deeg, W. E. Fitzsimmons, T. Furlong, J. A. Hansen, et al. “FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors.” Blood 88, no. 9 (November 1, 1996): 3634–41.Link to Item
-
Walters, M. C., M. Patience, W. Leisenring, J. R. Eckman, J. P. Scott, W. C. Mentzer, S. C. Davies, et al. “Bone marrow transplantation for sickle cell disease.” N Engl J Med 335, no. 6 (August 8, 1996): 369–76. https://doi.org/10.1056/NEJM199608083350601.Full Text Link to Item
-
Martin, P. J., B. J. Nelson, F. R. Appelbaum, C. Anasetti, H. J. Deeg, J. A. Hansen, G. B. McDonald, et al. “Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation.” Blood 88, no. 3 (August 1, 1996): 824–30.Link to Item
-
Flowers, M. E., K. M. Sullivan, and H. J. Deeg. “Graft-versus-host reactions: anti-leukemia effects of donor T cells.” Transplant Proc 28, no. 3 (June 1996): 1184–85.Link to Item
-
Kiem, H. P., G. B. McDonald, D. Myerson, C. L. Spurgeon, H. J. Deeg, J. E. Sanders, K. Doney, et al. “Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors.” Biol Blood Marrow Transplant 2, no. 2 (May 1996): 93–99.Link to Item
-
Sullivan, K. M. “Immunomodulation in allogeneic marrow transplantation: use of intravenous immune globulin to suppress acute graft-versus-host disease.” Clin Exp Immunol 104 Suppl 1 (May 1996): 43–48.Link to Item
-
Walters, M. C., M. Patience, W. Leisenring, J. R. Eckman, G. R. Buchanan, Z. R. Rogers, N. E. Olivieri, et al. “Barriers to bone marrow transplantation for sickle cell anemia.” Biol Blood Marrow Transplant 2, no. 2 (May 1996): 100–104.Link to Item
-
Anderson, J. E., C. Anasetti, F. R. Appelbaum, G. Schoch, T. A. Gooley, J. A. Hansen, C. D. Buckner, J. E. Sanders, K. M. Sullivan, and R. Storb. “Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia.” Br J Haematol 93, no. 1 (April 1996): 59–67. https://doi.org/10.1046/j.1365-2141.1996.4811022.x.Full Text Link to Item
-
Sanders, J. E., J. Hawley, W. Levy, T. Gooley, C. D. Buckner, H. J. Deeg, K. Doney, et al. “Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation.” Blood 87, no. 7 (April 1, 1996): 3045–52.Link to Item
-
Langston, A. A., J. E. Sanders, H. J. Deeg, S. W. Crawford, C. Anasetti, K. M. Sullivan, M. E. Flowers, and R. Storb. “Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita.” Br J Haematol 92, no. 3 (March 1996): 758–65. https://doi.org/10.1046/j.1365-2141.1996.424984.x.Full Text Link to Item
-
Stern, J. M., C. H. Chesnut, B. Bruemmer, K. M. Sullivan, P. S. Lenssen, S. N. Aker, and J. Sanders. “Bone density loss during treatment of chronic GVHD.” Bone Marrow Transplant 17, no. 3 (March 1996): 395–400.Link to Item
-
Flowers, M. E., J. Zanis, R. Pasquini, H. J. Deeg, R. Ribeiro, G. Longton, C. R. Medeiros, K. Doney, J. Sanders, and J. Bryant. “Marrow transplantation for Fanconi anaemia: conditioning with reduced doses of cyclophosphamide without radiation.” Br J Haematol 92, no. 3 (March 1996): 699–706. https://doi.org/10.1046/j.1365-2141.1996.363898.x.Full Text Link to Item
-
Sullivan, K. M., J. Storek, K. J. Kopecky, J. Jocom, G. Longton, M. Flowers, M. Siadak, et al. “A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.” Biol Blood Marrow Transplant 2, no. 1 (February 1996): 44–53.Link to Item
-
Wagner, J. L., H. J. Deeg, K. Seidel, C. Anasetti, K. Doney, J. Sanders, K. M. Sullivan, and R. Storb. “Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience.” Transplantation 61, no. 1 (January 15, 1996): 54–61. https://doi.org/10.1097/00007890-199601150-00012.Full Text Link to Item
-
Anderson, J. E., F. R. Appelbaum, G. Schoch, T. Gooley, C. Anasetti, W. I. Bensinger, E. Bryant, et al. “Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors.” Blood 87, no. 1 (January 1, 1996): 51–58.Link to Item
-
Sullivan, K. M. “Secondary immunodeficiencies and stem cell transplantation: issues of administration and safety of intravenous immunoglobulin.” Clin Ther 18 Suppl B (1996): 126–36. https://doi.org/10.1016/s0149-2918(96)80204-9.Full Text Link to Item
-
Sullivan, K. “IVIG in bone marrow transplantation.” P and T 21, no. 4 SUPPL. (January 1, 1996).
-
Anderson, J. E., F. R. Appelbaum, G. Schoch, T. Gooley, C. Anasetti, W. I. Bensinger, E. Bryant, C. D. Buckner, T. Chauncey, and R. A. Clift. “Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.” J Clin Oncol 14, no. 1 (January 1996): 220–26. https://doi.org/10.1200/JCO.1996.14.1.220.Full Text Link to Item
-
Deeg, H. J., G. Socié, G. Schoch, M. Henry-Amar, R. P. Witherspoon, A. Devergie, K. M. Sullivan, E. Gluckman, and R. Storb. “Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.” Blood 87, no. 1 (January 1, 1996): 386–92.Link to Item
-
Balduzzi, A., T. Gooley, C. Anasetti, J. E. Sanders, P. J. Martin, E. W. Petersdorf, F. R. Appelbaum, et al. “Unrelated donor marrow transplantation in children.” Blood 86, no. 8 (October 15, 1995): 3247–56.Link to Item
-
Kalhs, P., I. Schwarzinger, G. Anderson, M. Mori, R. A. Clift, R. Storb, C. D. Buckner, F. R. Appelbaum, J. A. Hansen, and K. M. Sullivan. “A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia.” Blood 86, no. 5 (September 1, 1995): 2028–32.Link to Item
-
Storb, R., C. Anasetti, F. R. Appelbaum, H. J. Deeg, K. Doney, P. Martin, R. Nash, K. Sullivan, and R. Witherpoon. “Immunosuppressive agents for prevention of graft-versus-host disease.” Bone Marrow Transplantation 15, no. SUPPL. 1 (July 26, 1995).
-
Doney, K. C., R. Storb, K. Beach, C. Anasetti, H. J. Deeg, J. A. Hansen, P. J. Martin, R. A. Nash, M. M. Schubert, and K. M. Sullivan. “A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplants.” Transplantation 60, no. 1 (July 15, 1995): 55–58. https://doi.org/10.1097/00007890-199507150-00011.Full Text Link to Item
-
Nash, R. A., R. Etzioni, R. Storb, T. Furlong, T. Gooley, C. Anasetti, F. R. Appelbaum, K. Doney, P. Martin, and J. Slattery. “Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study.” Blood 85, no. 12 (June 15, 1995): 3746–53.Link to Item
-
Benyunes, M. C., K. M. Sullivan, H. J. Deeg, M. Mori, W. Meyer, L. Fisher, R. Bensinger, M. K. Jack, J. Hicks, and R. Witherspoon. “Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation.” Int J Radiat Oncol Biol Phys 32, no. 3 (June 15, 1995): 661–70. https://doi.org/10.1016/0360-3016(94)00392-x.Full Text Link to Item
-
Radich, J. P., G. Gehly, T. Gooley, E. Bryant, R. A. Clift, S. Collins, S. Edmands, J. Kirk, A. Lee, and P. Kessler. “Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients.” Blood 85, no. 9 (May 1, 1995): 2632–38.Link to Item
-
Demirer, T., C. H. Weaver, C. D. Buckner, F. B. Petersen, W. I. Bensinger, J. Sanders, R. A. Clift, K. Lilleby, C. Anasetti, and P. Martin. “High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy.” J Clin Oncol 13, no. 3 (March 1995): 596–602. https://doi.org/10.1200/JCO.1995.13.3.596.Full Text Link to Item
-
Walters, M. C., K. M. Sullivan, F. Bernaudin, G. Souillet, J. P. Vannier, F. L. Johnson, C. Lenarsky, D. Powars, N. Bunin, and K. Ohene-Frempong. “Neurologic complications after allogeneic marrow transplantation for sickle cell anemia.” Blood 85, no. 4 (February 15, 1995): 879–84.Link to Item
-
Bush, N. E., M. Haberman, G. Donaldson, and K. M. Sullivan. “Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation.” Soc Sci Med 40, no. 4 (February 1995): 479–90. https://doi.org/10.1016/0277-9536(94)00153-k.Full Text Link to Item
-
Clift, R. A., C. D. Buckner, E. D. Thomas, E. Bryant, C. Anasetti, W. I. Bensinger, R. Bowden, H. J. Deeg, K. C. Doney, and L. D. Fisher. “Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia.” Blood 84, no. 12 (December 15, 1994): 4368–73.Link to Item
-
Weaver, C. H., R. A. Clift, H. J. Deeg, R. Storb, F. R. Appelbaum, W. Bensinger, K. Doney, J. A. Hansen, P. O. Martin, and J. Sanders. “Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia.” Bone Marrow Transplant 14, no. 6 (December 1994): 885–93.Link to Item
-
Weaver, C. H., F. B. Petersen, F. R. Appelbaum, W. I. Bensinger, O. Press, P. Martin, B. Sandmaier, H. J. Deeg, J. A. Hansen, and M. Brunvand. “High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma.” J Clin Oncol 12, no. 12 (December 1994): 2559–66. https://doi.org/10.1200/JCO.1994.12.12.2559.Full Text Link to Item
-
Robinson, N., and K. M. Sullivan. “Complications of allogeneic bone marrow transplantation.” Curr Opin Hematol 1, no. 6 (November 1994): 406–11.Link to Item
-
Clift, R. A., C. D. Buckner, E. D. Thomas, W. I. Bensinger, R. Bowden, E. Bryant, H. J. Deeg, K. C. Doney, L. D. Fisher, and J. A. Hansen. “Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide.” Blood 84, no. 6 (September 15, 1994): 2036–43.Link to Item
-
Siadak, M., and K. M. Sullivan. “The management of chronic graft-versus-host disease.” Blood Rev 8, no. 3 (September 1994): 154–60. https://doi.org/10.1016/0268-960x(94)90076-t.Full Text Link to Item
-
Anasetti, C., J. A. Hansen, T. A. Waldmann, F. R. Appelbaum, J. Davis, H. J. Deeg, K. Doney, P. J. Martin, R. Nash, and R. Storb. “Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor.” Blood 84, no. 4 (August 15, 1994): 1320–27.Link to Item
-
Storb, R., R. Etzioni, C. Anasetti, F. R. Appelbaum, C. D. Buckner, W. Bensinger, E. Bryant, et al. “Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.” Blood 84, no. 3 (August 1, 1994): 941–49. https://doi.org/10.1182/blood.v84.3.941.bloodjournal843941.Full Text
-
Storb, R., R. Etzioni, C. Anasetti, F. R. Appelbaum, C. D. Buckner, W. Bensinger, E. Bryant, R. Clift, H. J. Deeg, and K. Doney. “Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.” Blood 84, no. 3 (August 1, 1994): 941–49.Link to Item
-
Siadak, M. F., K. Kopecky, and K. M. Sullivan. “Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation.” Clin Exp Immunol 97 Suppl 1, no. Suppl 1 (July 1994): 53–57.Link to Item
-
Deeg, H. J., C. Anasetti, E. Petersdorf, R. Storb, K. Doney, J. A. Hansen, J. Sanders, K. M. Sullivan, and F. R. Appelbaum. “Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors.” Blood 83, no. 11 (June 1, 1994): 3417–18.Link to Item
-
Storb, R., W. Leisenring, H. J. Deeg, C. Anasetti, F. Appelbaum, W. Bensinger, C. D. Buckner, R. Clift, K. Doney, and J. Hansen. “Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia.” Blood 83, no. 9 (May 1, 1994): 2749–50.Link to Item
-
Stevens, C. D. “The case for the Clinton plan for health care reform.” N Engl J Med 330, no. 15 (April 14, 1994): 1086–87.Link to Item
-
Seidler, C. W., L. E. Mills, M. E. Flowers, and K. M. Sullivan. “Spontaneous factor VIII inhibitor occurring in association with chronic graft-versus-host disease.” Am J Hematol 45, no. 3 (March 1994): 240–43. https://doi.org/10.1002/ajh.2830450309.Full Text Link to Item
-
Johnson, F. L., W. C. Mentzer, K. A. Kalinyak, K. M. Sullivan, and M. R. Abboud. “Bone marrow transplantation for sickle cell disease. The United States experience.” Am J Pediatr Hematol Oncol 16, no. 1 (February 1994): 22–26.Link to Item
-
Sanders, J. E., R. Storb, C. Anasetti, H. J. Deeg, K. Doney, K. M. Sullivan, R. P. Witherspoon, and J. Hansen. “Marrow transplant experience for children with severe aplastic anemia.” Am J Pediatr Hematol Oncol 16, no. 1 (February 1994): 43–49.Link to Item
-
Walters, M. C., K. M. Sullivan, R. J. O’Reilly, F. Boulad, J. Brockstein, K. Blume, M. Amylon, F. L. Johnson, M. Klemperer, and J. Graham-Pole. “Bone marrow transplantation for thalassemia. The USA experience.” Am J Pediatr Hematol Oncol 16, no. 1 (February 1994): 11–17.Link to Item
-
Anderson, J. E., M. R. Litzow, F. R. Appelbaum, G. Schoch, L. D. Fisher, C. D. Buckner, F. B. Petersen, S. W. Crawford, O. W. Press, and J. E. Sanders. “Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.” J Clin Oncol 11, no. 12 (December 1993): 2342–50. https://doi.org/10.1200/JCO.1993.11.12.2342.Full Text Link to Item
-
Doney, K., C. D. Buckner, L. Fisher, F. B. Petersen, J. Sanders, F. R. Appelbaum, C. Anasetti, C. Badger, W. Bensinger, and H. J. Deeg. “Autologous bone marrow transplantation for acute lymphoblastic leukemia.” Bone Marrow Transplant 12, no. 4 (October 1993): 315–21.Link to Item
-
Anderson, J. E., F. R. Appelbaum, L. D. Fisher, G. Schoch, H. Shulman, C. Anasetti, W. I. Bensinger, E. Bryant, C. D. Buckner, and K. Doney. “Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome.” Blood 82, no. 2 (July 15, 1993): 677–81.Link to Item
-
Greinix, H. T., R. Storb, J. E. Sanders, H. J. Deeg, K. C. Doney, K. M. Sullivan, and R. P. Witherspoon. “Long-term survival and cure after marrow transplantation for congenital hypoplastic anaemia (Diamond-Blackfan syndrome).” Br J Haematol 84, no. 3 (July 1993): 515–20. https://doi.org/10.1111/j.1365-2141.1993.tb03109.x.Full Text Link to Item
-
Sullivan, K. M. “Marrow transplantation for disorders of hematopoiesis.” Leukemia 7, no. 7 (July 1993): 1098–99.Link to Item
-
Petersen, F. B., M. H. Lynch, R. A. Clift, F. R. Appelbaum, J. E. Sanders, W. I. Bensinger, M. C. Benyunes, K. Doney, A. Fefer, and P. Martin. “Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission.” J Clin Oncol 11, no. 7 (July 1993): 1353–60. https://doi.org/10.1200/JCO.1993.11.7.1353.Full Text Link to Item
-
Weaver, C. H., F. R. Appelbaum, F. B. Petersen, R. Clift, J. Singer, O. Press, W. Bensinger, J. Bianco, P. Martin, and C. Anasetti. “High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy.” J Clin Oncol 11, no. 7 (July 1993): 1329–35. https://doi.org/10.1200/JCO.1993.11.7.1329.Full Text Link to Item
-
Russell, N., S. Rogers, and A. Hunter. “Risk factors for acute graft-versus-host disease associated with cyclosporine and methotrexate prophylaxis.” Blood 81, no. 7 (April 1, 1993): 1972–74.Link to Item
-
Syrjala, K. L., M. K. Chapko, P. P. Vitaliano, C. Cummings, and K. M. Sullivan. “Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning.” Bone Marrow Transplant 11, no. 4 (April 1993): 319–27.Link to Item
-
Oliveira, J. S. de, S. B. Auerbach, K. M. Sullivan, and G. E. Sale. “Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan.” Bone Marrow Transplant 11, no. 2 (February 1993): 163–67.Link to Item
-
Beatty, P. G., C. Anasetti, J. A. Hansen, G. M. Longton, J. E. Sanders, P. J. Martin, E. M. Mickelson, S. Y. Choo, E. W. Petersdorf, and M. S. Pepe. “Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus.” Blood 81, no. 1 (January 1, 1993): 249–53.Link to Item
-
Haberman, M., N. Bush, K. Young, and K. M. Sullivan. “Quality of life of adult long-term survivors of bone marrow transplantation: a qualitative analysis of narrative data.” Oncol Nurs Forum 20, no. 10 (1993): 1545–53.Link to Item
-
Anasetti, C., P. J. Martin, R. Storb, F. R. Appelbaum, P. G. Beatty, J. Davis, K. Doney, H. F. Hill, P. Stewart, and K. M. Sullivan. “Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody.” Transplantation 54, no. 5 (November 1992): 844–51. https://doi.org/10.1097/00007890-199211000-00015.Full Text Link to Item
-
Clift, R. A., C. D. Buckner, F. R. Appelbaum, G. Schoch, F. B. Petersen, W. I. Bensinger, J. Sanders, K. M. Sullivan, R. Storb, and J. Singer. “Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia.” J Clin Oncol 10, no. 11 (November 1992): 1723–29. https://doi.org/10.1200/JCO.1992.10.11.1723.Full Text Link to Item
-
Tanaka, K., T. Aki, H. M. Shulman, K. M. Sullivan, A. Tanaka, and R. Nagasako. “Two cases of transfusion-associated graft-vs-host disease after open heart surgery.” Arch Dermatol 128, no. 11 (November 1992): 1503–6.Link to Item
-
Nash, R. A., M. S. Pepe, R. Storb, G. Longton, M. Pettinger, C. Anasetti, F. R. Appelbaum, R. A. Bowden, H. J. Deeg, and K. Doney. “Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.” Blood 80, no. 7 (October 1, 1992): 1838–45.Link to Item
-
Storb, R., M. Pepe, H. J. Deeg, C. Anasetti, F. R. Appelbaum, W. Bensinger, C. D. Buckner, R. A. Cliff, K. Doney, and J. Hansen. “Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.” Blood 80, no. 2 (July 15, 1992): 560–61.Link to Item
-
Petersen, F. B., C. D. Buckner, F. R. Appelbaum, J. E. Sanders, W. I. Bensinger, R. Storb, H. J. Deeg, R. P. Witherspoon, K. M. Sullivan, and R. A. Clift. “Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.” Bone Marrow Transplant 10, no. 1 (July 1992): 83–88.Link to Item
-
Storb, R., P. Martin, H. J. Deeg, J. E. Sanders, M. Pepe, J. Singer, C. Anasetti, P. Stewart, F. R. Appelbaum, and K. M. Sullivan. “Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia.” Blood 79, no. 11 (June 1, 1992): 3091–92.Link to Item
-
Nemunaitis, J., C. Anasetti, R. Storb, J. A. Bianco, C. D. Buckner, N. Onetto, P. Martin, J. Sanders, K. Sullivan, and M. Mori. “Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors.” Blood 79, no. 10 (May 15, 1992): 2572–77.Link to Item
-
Doney, K., M. Pepe, R. Storb, E. Bryant, C. Anasetti, F. R. Appelbaum, C. D. Buckner, J. Sanders, J. Singer, and K. Sullivan. “Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone.” Blood 79, no. 10 (May 15, 1992): 2566–71.Link to Item
-
Grigg, A., and G. Phillips. “Prophylaxis of cytomegalovirus disease in allogeneic bone marrow transplantation.” J Infect Dis 165, no. 5 (May 1992): 972–73. https://doi.org/10.1093/infdis/165.5.972.Full Text Link to Item
-
Fried, R. H., C. S. Murakami, L. D. Fisher, R. A. Willson, K. M. Sullivan, and G. B. McDonald. “Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver.” Ann Intern Med 116, no. 8 (April 15, 1992): 624–29. https://doi.org/10.7326/0003-4819-116-8-624.Full Text Link to Item
-
Flowers, M. E., K. C. Doney, R. Storb, H. J. Deeg, J. E. Sanders, K. M. Sullivan, E. Bryant, R. P. Witherspoon, F. R. Appelbaum, and C. D. Buckner. “Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience.” Bone Marrow Transplant 9, no. 3 (March 1992): 167–73.Link to Item
-
DeGast, G. C., E. M. Mickelson, P. G. Beatty, D. Amos, K. M. Sullivan, H. G. Schoch, E. D. Thomas, and J. A. Hansen. “Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia.” Bone Marrow Transplant 9, no. 2 (February 1992): 87–90.Link to Item
-
Deeg, H. J., K. Erickson, R. Storb, and K. M. Sullivan. “Photoinactivation of lymphohemopoietic cells: studies in transfusion medicine and bone marrow transplantation.” Blood Cells 18, no. 1 (1992): 151–61.Link to Item
-
Petersen, F. B., H. J. Deeg, C. D. Buckner, F. R. Appelbaum, R. Storb, R. A. Clift, J. E. Sanders, W. I. Bensinger, R. P. Witherspoon, and K. M. Sullivan. “Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial.” Int J Radiat Oncol Biol Phys 23, no. 5 (1992): 1027–32. https://doi.org/10.1016/0360-3016(92)90909-2.Full Text Link to Item
-
Storb, R., G. Longton, C. Anasetti, F. R. Appelbaum, P. Beatty, W. Bensinger, S. Crawford, H. J. Deeg, K. Doney, and A. Fefer. “Changing trends in marrow transplantation for aplastic anemia.” Bone Marrow Transplant 10 Suppl 1 (1992): 45–52.Link to Item
-
Sullivan, K. M., M. Mori, J. Sanders, M. Siadak, R. P. Witherspoon, C. Anasetti, F. R. Appelbaum, W. Bensinger, R. Bowden, and C. D. Buckner. “Late complications of allogeneic and autologous marrow transplantation.” Bone Marrow Transplant 10 Suppl 1 (1992): 127–34.Link to Item
-
Stockschlaeder, M., R. Storb, M. Pepe, G. Longton, G. McDonald, C. Anasetti, F. Appelbaum, K. Doney, P. Martin, and K. Sullivan. “A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation.” Br J Haematol 80, no. 1 (January 1992): 49–54. https://doi.org/10.1111/j.1365-2141.1992.tb06399.x.Full Text Link to Item
-
Wahl, R. L., N. A. Swanson, J. W. Johnson, R. Natale, N. A. Petry, S. Mallette, S. Kasina, J. Reno, K. Sullivan, and P. Abrams. “Clinical experience with Tc-99m labeled (N2S2) anti-melanoma antibody fragments and single photon emission computed tomography.” Am J Physiol Imaging 7, no. 2 (1992): 48–58.Link to Item
-
Witherspoon, R. P., R. Storb, M. Pepe, G. Longton, and K. M. Sullivan. “Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone.” Blood 79, no. 1 (January 1, 1992): 289–91.Link to Item
-
Van der Jagt, R. H., F. R. Appelbaum, F. B. Petersen, C. L. Bigelow, L. D. Fisher, G. H. Schoch, C. D. Buckner, J. E. Sanders, R. Storb, and K. M. Sullivan. “Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy.” Bone Marrow Transplant 8, no. 3 (September 1991): 211–15.Link to Item
-
Storb, R., J. E. Sanders, M. Pepe, C. Anasetti, F. R. Appelbaum, C. D. Buckner, H. J. Deeg, K. Doney, J. Hansen, and P. Martin. “Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts.” Blood 78, no. 4 (August 15, 1991): 1144–45.Link to Item
-
Horst, H. A., N. Schmitz, C. Glinike, H. Löffler, and R. Laufs. “Seroconversion for hepatitis C virus antibody in bone marrow recipients treated with immune globulin.” N Engl J Med 325, no. 2 (July 11, 1991): 132–33. https://doi.org/10.1056/NEJM199107113250214.Full Text Link to Item
-
Storb, R., C. Anasetti, F. Appelbaum, W. Bensinger, C. D. Buckner, R. Clift, H. J. Deeg, K. Doney, J. Hansen, and T. Loughran. “Marrow transplantation for severe aplastic anemia and thalassemia major.” Semin Hematol 28, no. 3 (July 1991): 235–39.Link to Item
-
Sullivan, K. M., and C. D. Reid. “Introduction to a symposium on sickle cell anemia: current results of comprehensive care and the evolving role of bone marrow transplantation.” Semin Hematol 28, no. 3 (July 1991): 177–79.Link to Item
-
Buckner, C. D., R. A. Clift, F. R. Appelbaum, R. Storb, A. Fefer, F. B. Petersen, J. E. Sanders, K. Sullivan, E. D. Thomas, and J. A. Hansen. “Effects of treatment regimens on post marrow transplant relapse.” Semin Hematol 28, no. 3 Suppl 4 (July 1991): 32–34.Link to Item
-
Sullivan, K. M., E. Agura, C. Anasetti, F. Appelbaum, C. Badger, S. Bearman, K. Erickson, M. Flowers, J. Hansen, and T. Loughran. “Chronic graft-versus-host disease and other late complications of bone marrow transplantation.” Semin Hematol 28, no. 3 (July 1991): 250–59.Link to Item
-
Doney, K., L. D. Fisher, F. R. Appelbaum, C. D. Buckner, R. Storb, J. Singer, A. Fefer, C. Anasetti, P. Beatty, and W. Bensinger. “Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival.” Bone Marrow Transplant 7, no. 6 (June 1991): 453–59.Link to Item
-
Anasetti, C., P. J. Martin, R. Storb, F. R. Appelbaum, P. G. Beatty, E. Calori, J. Davis, K. Doney, T. Reichert, and P. Stewart. “Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3.” Bone Marrow Transplant 7, no. 5 (May 1991): 375–81.Link to Item
-
Clift, R. A., C. D. Buckner, F. R. Appelbaum, E. Bryant, S. I. Bearman, F. B. Petersen, L. D. Fisher, C. Anasetti, P. Beatty, and W. I. Bensinger. “Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens.” Blood 77, no. 8 (April 15, 1991): 1660–65.Link to Item
-
deGast, G. C., P. G. Beatty, D. Amos, E. M. Mickelson, K. M. Sullivan, J. E. Anderson, E. R. Giblett, F. Appelbaum, R. Storb, and H. J. Deeg. “Transfusions shortly before HLA-matched marrow transplantation for leukemia are associated with a decrease in chronic graft-versus-host disease.” Bone Marrow Transplant 7, no. 4 (April 1991): 293–95.Link to Item
-
“Intravenous IgG to prevent graft-versus-host disease after bone marrow transplantation.” N Engl J Med 324, no. 9 (February 28, 1991): 631–33. https://doi.org/10.1056/NEJM199102283240912.Full Text Link to Item
-
Beatty, P. G., J. A. Hansen, G. M. Longton, E. D. Thomas, J. E. Sanders, P. J. Martin, S. I. Bearman, C. Anasetti, E. W. Petersdorf, and E. M. Mickelson. “Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies.” Transplantation 51, no. 2 (February 1991): 443–47. https://doi.org/10.1097/00007890-199102000-00034.Full Text Link to Item
-
Nemunaitis, J., J. W. Singer, C. D. Buckner, T. Mori, J. Laponi, R. Hill, R. Storb, K. M. Sullivan, J. A. Hansen, and F. R. Appelbaum. “Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy.” Bone Marrow Transplant 7, no. 1 (January 1991): 49–52.Link to Item
-
Sullivan, K. M., K. J. Kopecky, C. D. Buckner, and R. Storb. “Intravenous IgG to prevent graft-versus-host disease after bone marrow transplantation (Reply).” New England Journal of Medicine 324, no. 9 (January 1, 1991): 632–33.
-
Tanaka, K., K. M. Sullivan, H. M. Shulman, G. E. Sale, and A. Tanaka. “A clinical review: cutaneous manifestations of acute and chronic graft-versus-host disease following bone marrow transplantation.” J Dermatol 18, no. 1 (January 1991): 11–17. https://doi.org/10.1111/j.1346-8138.1991.tb03032.x.Full Text Link to Item
-
Friedman, S., K. Sullivan, D. Salk, W. B. Nelp, R. J. Griep, D. H. Johnson, M. J. Blend, R. Aye, V. Suppers, and P. G. Abrams. “Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies.” Hematol Oncol Clin North Am 4, no. 6 (December 1990): 1069–78.Link to Item
-
Clift, R. A., C. D. Buckner, F. R. Appelbaum, S. I. Bearman, F. B. Petersen, L. D. Fisher, C. Anasetti, P. Beatty, W. I. Bensinger, and K. Doney. “Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.” Blood 76, no. 9 (November 1, 1990): 1867–71.Link to Item
-
Martin, P. J., G. Schoch, L. Fisher, V. Byers, C. Anasetti, F. R. Appelbaum, P. G. Beatty, K. Doney, G. B. McDonald, and J. E. Sanders. “A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment.” Blood 76, no. 8 (October 15, 1990): 1464–72.Link to Item
-
Sullivan, K. M., K. J. Kopecky, J. Jocom, L. Fisher, C. D. Buckner, J. D. Meyers, G. W. Counts, R. A. Bowden, F. B. Peterson, and R. P. Witherspoon. “Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.” N Engl J Med 323, no. 11 (September 13, 1990): 705–12. https://doi.org/10.1056/NEJM199009133231103.Full Text Link to Item
-
Storb, R., M. Pepe, C. Anasetti, F. R. Appelbaum, P. Beatty, K. Doney, P. Martin, P. Stewart, K. M. Sullivan, and R. Witherspoon. “What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?” Blood 76, no. 5 (September 1, 1990): 1037–45.Link to Item
-
Anasetti, C., P. J. Martin, J. A. Hansen, F. R. Appelbaum, P. G. Beatty, K. Doney, S. Harkonen, A. Jackson, T. Reichert, and P. Stewart. “A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease.” Transplantation 50, no. 1 (July 1990): 49–54. https://doi.org/10.1097/00007890-199007000-00010.Full Text Link to Item
-
Loughran, T. P., K. Sullivan, T. Morton, C. Beckham, M. Schubert, R. Witherspoon, G. Sale, J. Sanders, L. Fisher, and H. Shulman. “Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation.” Blood 76, no. 1 (July 1, 1990): 228–34.Link to Item
-
Higano, C. S., M. Brixey, E. M. Bryant, D. M. Durnam, K. Doney, K. M. Sullivan, and J. W. Singer. “Durable complete remission of acute nonlymphocytic leukemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation. A case report of a probable graft-versus-leukemia effect.” Transplantation 50, no. 1 (July 1990): 175–77.Link to Item
-
Schubert, M. A., K. M. Sullivan, M. M. Schubert, J. Nims, M. Hansen, J. E. Sanders, J. O’Quigley, R. P. Witherspoon, C. D. Buckner, and R. Storb. “Gynecological abnormalities following allogeneic bone marrow transplantation.” Bone Marrow Transplant 5, no. 6 (June 1990): 425–30.Link to Item
-
Sullivan, K. M., M. F. Siadak, and R. P. Witherspoon. “Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation.” Transplant Proc 22, no. 3 (June 1990): 1336–38.Link to Item
-
Lenssen, P., M. E. Sherry, C. L. Cheney, J. W. Nims, K. M. Sullivan, J. M. Stern, G. Moe, and S. N. Aker. “Prevalence of nutrition-related problems among long-term survivors of allogeneic marrow transplantation.” J Am Diet Assoc 90, no. 6 (June 1990): 835–42.Link to Item
-
Sullivan, K. M., and F. R. Appelbaum. “Comparative trials of chemotherapy and bone marrow transplantation in acute nonlymphocytic leukemia.” Rinsho Ketsueki 31, no. 5 (May 1990): 527–33.Link to Item
-
Flowers, M. E., M. S. Pepe, G. Longton, K. C. Doney, D. Monroe, R. P. Witherspoon, K. M. Sullivan, and R. Storb. “Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation.” Br J Haematol 74, no. 4 (April 1990): 492–96. https://doi.org/10.1111/j.1365-2141.1990.tb06340.x.Full Text Link to Item
-
Petersen, F. B., F. R. Appelbaum, R. Hill, L. D. Fisher, C. L. Bigelow, J. E. Sanders, K. M. Sullivan, W. I. Bensinger, R. P. Witherspoon, and R. Storb. “Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle.” J Clin Oncol 8, no. 4 (April 1990): 638–47. https://doi.org/10.1200/JCO.1990.8.4.638.Full Text Link to Item
-
Lishner, M., and R. Lang. “Secondary cancers after bone marrow transplantation.” N Engl J Med 322, no. 12 (March 22, 1990): 853. https://doi.org/10.1056/NEJM199003223221216.Full Text Link to Item
-
Hill, Harlan F., Richard C. Chapman, Judy A. Kornell, Keith M. Sullivan, Louis C. Saeger, and Costantino Benedetti. “Self-administration of morphine in bone marrow transplant patients reduces drug requirement.” Pain 40, no. 2 (February 1990): 121–29. https://doi.org/10.1016/0304-3959(90)90062-I.Full Text Link to Item
-
Appelbaum, F. R., J. Barrall, R. Storb, L. D. Fisher, G. Schoch, R. E. Ramberg, H. Shulman, et al. “Bone marrow transplantation for patients with myelodysplasia: Pretreatment variables and outcome.” Annals of Internal Medicine 112, no. 8 (1990): 590–97.
-
Schubert, M. M., and K. M. Sullivan. “Recognition, incidence, and management of oral graft-versus-host disease.” Nci Monogr, no. 9 (1990): 135–43.Link to Item
-
Storb, R., F. Appelbaum, C. D. Buckner, R. Clift, C. P. A. Beatty, J. Bianco, K. Doney, J. Hansen, P. Martin, and E. al. “HLA-identical transplantation in the leukemias without T-cell depletion.” Bone Marrow Transplantation 6, no. SUPPL. 1 (1990): 80–84.
-
Sullivan, K. M. “Chronic graft-versus-host disease.” Cancer Treat Res 50 (1990): 79–98. https://doi.org/10.1007/978-1-4613-1493-6_5.Full Text Link to Item
-
Sullivan, K. M., J. Meyers, F. B. Petersen, R. Bowden, G. C. Counts, M. Banaji, M. Schubert, J. Clark, R. A. Clift, and F. R. Appelbaum. “Supportive care of the marrow transplant recipient: the Seattle Experience.” Haematol Blood Transfus 33 (1990): 539–45. https://doi.org/10.1007/978-3-642-74643-7_96.Full Text Link to Item
-
Sanders, J., K. Sullivan, R. Witherspoon, K. Doney, C. Anasetti, P. Beatty, and F. B. Petersen. “Long term effects and quality of life in children and adults after marrow transplantation.” Bone Marrow Transplant 4 Suppl 4 (December 1989): 27–29.Link to Item
-
Petersen, F. B., C. D. Buckner, F. R. Appelbaum, R. A. Clift, J. E. Sanders, W. I. Bensinger, R. Storb, R. P. Witherspoon, K. M. Sullivan, and S. I. Bearman. “Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.” Bone Marrow Transplant 4, no. 6 (November 1989): 617–23.Link to Item
-
Yee, G. C., T. R. McGuire, B. A. St Pierre, S. G. Self, R. A. Zager, K. M. Sullivan, and H. J. Deeg. “Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 months.” Bone Marrow Transplant 4, no. 6 (November 1989): 691–94.Link to Item
-
Sullivan, K. M. “Intravenous immune globulin prophylaxis in recipients of a marrow transplant.” J Allergy Clin Immunol 84, no. 4 Pt 2 (October 1989): 632–38. https://doi.org/10.1016/0091-6749(89)90202-9.Full Text Link to Item
-
Witherspoon, R. P., L. D. Fisher, G. Schoch, P. Martin, K. M. Sullivan, J. Sanders, H. J. Deeg, K. Doney, D. Thomas, and R. Storb. “Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia.” N Engl J Med 321, no. 12 (September 21, 1989): 784–89. https://doi.org/10.1056/NEJM198909213211203.Full Text Link to Item
-
Petersen, F. B., F. R. Appelbaum, C. L. Bigelow, C. D. Buckner, R. A. Clift, J. E. Sanders, R. Storb, K. M. Sullivan, P. L. Weiden, and A. Fefer. “High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.” Bone Marrow Transplant 4, no. 5 (September 1989): 483–88.Link to Item
-
Bearman, S. I., F. R. Appelbaum, A. Back, F. B. Petersen, C. D. Buckner, K. M. Sullivan, H. G. Schoch, L. D. Fisher, and E. D. Thomas. “Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.” J Clin Oncol 7, no. 9 (September 1989): 1288–94. https://doi.org/10.1200/JCO.1989.7.9.1288.Full Text Link to Item
-
Clark, J. G., S. W. Crawford, D. K. Madtes, and K. M. Sullivan. “Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course.” Ann Intern Med 111, no. 5 (September 1, 1989): 368–76. https://doi.org/10.7326/0003-4819-111-5-368.Full Text Link to Item
-
Storb, R., H. J. Deeg, M. Pepe, K. Doney, F. Appelbaum, P. Beatty, W. Bensinger, C. D. Buckner, R. Clift, and J. Hansen. “Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.” Br J Haematol 72, no. 4 (August 1989): 567–72. https://doi.org/10.1111/j.1365-2141.1989.tb04325.x.Full Text Link to Item
-
Sullivan, K. M. “Current status of bone marrow transplantation.” Transplant Proc 21, no. 3 Suppl 1 (June 1989): 41–50.Link to Item
-
Sullivan, K. M., and H. M. Shulman. “Chronic graft-versus-host disease, obliterative bronchiolitis, and graft-versus-leukemia effect: case histories.” Transplant Proc 21, no. 3 Suppl 1 (June 1989): 51–62.Link to Item
-
Sullivan, K. M., P. L. Weiden, R. Storb, R. P. Witherspoon, A. Fefer, L. Fisher, C. D. Buckner, C. Anasetti, F. R. Appelbaum, and C. Badger. “Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.” Blood 73, no. 6 (May 1, 1989): 1720–28.Link to Item
-
Sullivan, K. M., R. Storb, C. D. Buckner, A. Fefer, L. Fisher, P. L. Weiden, R. P. Witherspoon, F. R. Appelbaum, M. Banaji, and J. Hansen. “Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms.” N Engl J Med 320, no. 13 (March 30, 1989): 828–34. https://doi.org/10.1056/NEJM198903303201303.Full Text Link to Item
-
Chapko, M. K., K. L. Syrjala, L. Schilter, C. Cummings, and K. M. Sullivan. “Chemoradiotherapy toxicity during bone marrow transplantation: time course and variation in pain and nausea.” Bone Marrow Transplant 4, no. 2 (March 1989): 181–86.Link to Item
-
Hill, H. F., C. R. Chapman, T. L. Jackson, and K. M. Sullivan. “Assessment and management of donor pain following marrow harvest for allogeneic bone marrow transplantation.” Bone Marrow Transplant 4, no. 2 (March 1989): 157–61.Link to Item
-
Niederwieser, D., M. Pepe, R. Storb, R. Witherspoon, G. Longton, and K. Sullivan. “Factors predicting chronic graft-versus-host disease and survival after marrow transplantation for aplastic anemia.” Bone Marrow Transplant 4, no. 2 (March 1989): 151–56.Link to Item
-
Anasetti, C., W. Rybka, K. M. Sullivan, M. Banaji, and S. J. Slichter. “Graft-v-host disease is associated with autoimmune-like thrombocytopenia.” Blood 73, no. 4 (March 1989): 1054–58.Link to Item
-
Sullivan, K. M. “Congress review: progress and prospects in bone marrow transplantation.” Transplant Proc 21, no. 1 Pt 3 (February 1989): 2919–22.Link to Item
-
Sullivan, K. M., R. P. Witherspoon, R. Storb, C. D. Buckner, J. Sanders, and E. D. Thomas. “Long-term results of allogeneic bone marrow transplantation.” Transplant Proc 21, no. 1 Pt 3 (February 1989): 2926–28.Link to Item
-
Anasetti, C., D. Amos, P. G. Beatty, F. R. Appelbaum, W. Bensinger, C. D. Buckner, R. Clift, K. Doney, P. J. Martin, and E. Mickelson. “Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.” N Engl J Med 320, no. 4 (January 26, 1989): 197–204. https://doi.org/10.1056/NEJM198901263200401.Full Text Link to Item
-
Buckner, C. D., A. Fefer, W. I. Bensinger, R. Storb, B. G. Durie, F. R. Appelbaum, F. B. Petersen, P. Weiden, R. A. Clift, and J. E. Sanders. “Marrow transplantation for malignant plasma cell disorders: summary of the Seattle experience.” Eur J Haematol Suppl 51 (1989): 186–90. https://doi.org/10.1111/j.1600-0609.1989.tb01515.x.Full Text Link to Item
-
Hill, R. S., P. Mazza, D. Amos, C. D. Buckner, F. R. Appelbaum, P. Martin, B. J. Still, S. Sica, R. Berenson, and W. Bensinger. “Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation.” Bone Marrow Transplant 4, no. 1 (January 1989): 69–74.Link to Item
-
Sanders, J. E., C. D. Buckner, K. Sullivan, K. Doney, F. Appelbaum, R. Witherspoon, C. Anasetti, R. Storb, and E. D. Thomas. “Growth and development after bone marrow transplantation.” Prog Clin Biol Res 309 (1989): 375–82.Link to Item
-
Sullivan, K. M. “Intravenous immune globulin prophylaxis in recipients of a marrow transplant.” The Journal of Allergy and Clinical Immunology 84, no. 4 PART 2 (1989): 632–39.
-
Sullivan, K. M. “Intravenous immune globulin prophylaxis in recipients of a marrow transplant.” Journal of Allergy and Clinical Immunology 84, no. 4 II SUPPL. (January 1, 1989): 632–39.
-
Sullivan, K. M. “Congress review: Progress and prospects in bone marrow transplantation.” Transplantation Proceedings 21, no. 1 III (January 1, 1989): 2919–22.
-
Sullivan, K. M., C. D. Buckner, J. E. Sanders, C. Anasetti, F. R. Appelbaum, J. Clark, K. Doney, J. Meyers, G. Sale, and R. Storb. “Long-term complications of bone marrow transplantation.” Prog Clin Biol Res 309 (1989): 367–74.Link to Item
-
Sullivan, K. M., R. P. Witherspoon, R. Storb, C. D. Buckner, J. Sanders, and E. D. Thomas. “Long-term results of allogeneic bone marrow transplantation.” Transplantation Proceedings 21, no. 1 III (January 1, 1989): 2926–28.
-
Sullivan, K. M., R. Storb, R. P. Witherspoon, P. L. Weiden, C. Anasetti, F. R. Appelbaum, P. Beatty, et al. “Deletion of immunosuppressive prophylaxis after marrow transplantation increases hyperacute graft-versus-host disease but does not influence chronic graft-versus-host disease or relapse in patients with advanced leukemia.” Clinical Transplantation 3, no. 1 (January 1, 1989): 5–11.
-
Vansant, J., D. Johnson, M. Sandler, B. McCook, J. Hainsworth, A. Sonin, J. Clanton, K. Sullivan, D. Salk, and P. Abrams. “Technetium-99m labeled NR-LU-10 monoclonal antibody (MoAb) in assessing patients with carcinoma of the lung.” Journal of Nuclear Medicine 30, no. 11 (January 1, 1989).
-
Buckner, C. D., A. Fefer, W. I. Bensinger, R. Storb, B. G. Durie, F. R. Appelbaum, F. B. Petersen, et al. “Marrow transplantation for malignant plasma cell disorders: Summary of the Seattle experience.” European Journal of Haematology, Supplement 43, no. 51 (1989): 186–90.
-
Martin, P. J., R. A. Clift, L. D. Fisher, C. D. Buckner, J. A. Hansen, F. R. Appelbaum, K. C. Doney, K. M. Sullivan, R. P. Witherspoon, and R. Storb. “HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration.” Blood 72, no. 6 (December 1988): 1978–84.Link to Item
-
Anasetti, C., R. Storb, G. Longton, R. Witherspoon, K. Doney, K. M. Sullivan, and E. D. Thomas. “Donor buffy coat cell infusion after marrow transplantation for aplastic anemia.” Blood 72, no. 3 (September 1988): 1099–1100.Link to Item
-
Lum, L. G., J. E. Noges, P. Beatty, P. J. Martin, J. Deeg, K. C. Doney, T. Loughran, K. M. Sullivan, R. P. Witherspoon, and E. D. Thomas. “Transfer of specific immunity in marrow recipients given HLA-mismatched, T cell-depleted, or HLA-identical marrow grafts.” Bone Marrow Transplant 3, no. 5 (September 1988): 399–406.Link to Item
-
Martin, P. J., J. A. Hansen, B. Torok-Storb, D. Durnam, D. Przepiorka, J. O’Quigley, J. Sanders, K. M. Sullivan, R. P. Witherspoon, and H. J. Deeg. “Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants.” Bone Marrow Transplant 3, no. 5 (September 1988): 445–56.Link to Item
-
Witherspoon, R. P., K. M. Sullivan, L. G. Lum, S. Goehle, M. K. Atkinson, H. D. Ochs, K. C. Doney, J. A. Hansen, J. E. Sanders, and R. Storb. “Use of thymic grafts or thymic factors to augment immunologic recovery after bone marrow transplantation: brief report with 2 to 12 years' follow-up.” Bone Marrow Transplant 3, no. 5 (September 1988): 425–35.Link to Item
-
Sullivan, K. M., R. P. Witherspoon, R. Storb, H. J. Deeg, S. Dahlberg, J. E. Sanders, F. R. Appelbaum, K. C. Doney, P. Weiden, and C. Anasetti. “Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease.” Blood 72, no. 2 (August 1988): 555–61.Link to Item
-
Sullivan, K. M., R. P. Witherspoon, R. Storb, P. Weiden, N. Flournoy, S. Dahlberg, H. J. Deeg, J. E. Sanders, K. C. Doney, and F. R. Appelbaum. “Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.” Blood 72, no. 2 (August 1988): 546–54.Link to Item
-
Sanders, J. E., C. D. Buckner, D. Amos, W. Levy, F. R. Appelbaum, K. Doney, R. Storb, K. M. Sullivan, R. P. Witherspoon, and E. D. Thomas. “Ovarian function following marrow transplantation for aplastic anemia or leukemia.” J Clin Oncol 6, no. 5 (May 1988): 813–18. https://doi.org/10.1200/JCO.1988.6.5.813.Full Text Link to Item
-
Sanders, J. E., C. D. Buckner, E. D. Thomas, R. Fleischer, K. M. Sullivan, F. A. Appelbaum, and R. Storb. “Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia.” Blood 71, no. 4 (April 1988): 1144–46.Link to Item
-
Riddell, S., F. R. Appelbaum, C. D. Buckner, P. Stewart, R. Clift, J. Sanders, R. Storb, K. Sullivan, and E. D. Thomas. “High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia.” J Clin Oncol 6, no. 4 (April 1988): 576–82. https://doi.org/10.1200/JCO.1988.6.4.576.Full Text Link to Item
-
Storb, R., H. J. Deeg, L. Fisher, F. Appelbaum, C. D. Buckner, W. Bensinger, R. Clift, K. Doney, C. Irle, and R. McGuffin. “Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials.” Blood 71, no. 2 (February 1988): 293–98.Link to Item
-
Sanders, J. E., C. D. Buckner, K. M. Sullivan, K. Doney, F. Appelbaum, R. Witherspoon, R. Storb, and E. D. Thomas. “Growth and development in children after bone marrow transplantation.” Horm Res 30, no. 2–3 (1988): 92–97. https://doi.org/10.1159/000181036.Full Text Link to Item
-
Sanders, J. E., C. D. Buckner, R. A. Clift, A. Fefer, R. McGuffin, R. Storb, F. Appelbaum, W. Bensinger, P. Beatty, and K. Doney. “Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation.” Bone Marrow Transplant 3, no. 1 (January 1988): 11–19.Link to Item
-
Shulman, H. M., and K. M. Sullivan. “Graft-versus-host disease: allo- and autoimmunity after bone marrow transplantation.” Concepts Immunopathol 6 (1988): 141–65.Link to Item
-
Storb, R., C. Anasetti, F. R. Appelbaum, P. Beatty, H. J. Deeg, K. Doney, P. Martin, K. Sullivan, R. Witherspoon, and E. D. Thomas. “Predictive facts and prevention of acute graft-versus-host disease: The Seattle experience.” Bone Marrow Transplantation 3, no. SUPPL. 1 (January 1, 1988): 7–10.
-
Doney, K., C. D. Buckner, K. J. Kopecky, J. E. Sanders, F. R. Appelbaum, R. Clift, K. Sullivan, R. Witherspoon, R. Storb, and E. D. Thomas. “Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission.” Bone Marrow Transplant 2, no. 4 (December 1987): 355–63.Link to Item
-
Meyers, J. D., N. Flournoy, J. E. Sanders, R. W. McGuffin, B. A. Newton, L. D. Fisher, L. G. Lum, F. R. Appelbaum, K. Doney, and K. M. Sullivan. “Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation.” Ann Intern Med 107, no. 6 (December 1987): 809–16. https://doi.org/10.7326/0003-4819-107-6-809.Full Text Link to Item
-
Clark, J. G., D. A. Schwartz, N. Flournoy, K. M. Sullivan, S. W. Crawford, and E. D. Thomas. “Risk factors for airflow obstruction in recipients of bone marrow transplants.” Ann Intern Med 107, no. 5 (November 1987): 648–56. https://doi.org/10.7326/0003-4819-107-5-648.Full Text Link to Item
-
Sullivan, K. M. “Immunoglobulin therapy in bone marrow transplantation.” Am J Med 83, no. 4A (October 23, 1987): 34–45. https://doi.org/10.1016/0002-9343(87)90549-3.Full Text Link to Item
-
Clift, R. A., C. D. Buckner, E. D. Thomas, K. J. Kopecky, F. R. Appelbaum, M. Tallman, R. Storb, J. Sanders, K. Sullivan, and M. Banaji. “The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation.” Bone Marrow Transplant 2, no. 3 (October 1987): 243–58.Link to Item
-
Appelbaum, F. R., K. M. Sullivan, C. D. Buckner, R. A. Clift, H. J. Deeg, A. Fefer, R. Hill, J. Mortimer, P. E. Neiman, and J. E. Sanders. “Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.” J Clin Oncol 5, no. 9 (September 1987): 1340–47. https://doi.org/10.1200/JCO.1987.5.9.1340.Full Text Link to Item
-
Petersen, F. B., R. A. Bowden, M. Thornquist, J. D. Meyers, C. D. Buckner, G. W. Counts, N. Nelson, B. A. Newton, K. M. Sullivan, and J. McIver. “The effect of prophylactic intravenous immune globulin on the incidence of septicemia in marrow transplant recipients.” Bone Marrow Transplant 2, no. 2 (August 1987): 141–47.Link to Item
-
Storb, R., P. L. Weiden, K. M. Sullivan, F. R. Appelbaum, P. Beatty, C. D. Buckner, R. A. Clift, K. C. Doney, J. Hansen, and P. J. Martin. “Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin.” Blood 70, no. 1 (July 1987): 116–21.Link to Item
-
Sargur, M., C. D. Buckner, F. R. Appelbaum, P. Stewart, H. J. Deeg, P. L. Weiden, K. M. Sullivan, A. Fefer, and E. D. Thomas. “Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease.” J Clin Oncol 5, no. 5 (May 1987): 731–34. https://doi.org/10.1200/JCO.1987.5.5.731.Full Text Link to Item
-
Sale, G. E., B. B. Gallucci, M. M. Schubert, K. M. Sullivan, and E. D. Thomas. “Direct ultrastructural evidence of target-directed polarization by cytotoxic lymphocytes in lesions of human graft-vs-host disease.” Arch Pathol Lab Med 111, no. 4 (April 1987): 333–36.Link to Item
-
Witherspoon, R. P., R. Navari, R. Storb, K. M. Sullivan, K. Doney, P. Beatty, L. G. Lum, and E. D. Thomas. “Treatment of marrow graft recipients with thymopentin.” Bone Marrow Transplant 1, no. 4 (April 1987): 365–71.Link to Item
-
Doney, K., R. Storb, C. D. Buckner, R. McGuffin, R. Witherspoon, H. J. Deeg, F. R. Appelbaum, K. M. Sullivan, and E. D. Thomas. “Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens.” Exp Hematol 15, no. 3 (March 1987): 239–42.Link to Item
-
Gast, G. C. de, P. G. Beatty, D. Amos, K. Sullivan, J. E. Anderson, E. D. Thomas, and J. A. Hansen. “Transfusion effect on graft-versus-host disease and leukemic relapse in HLA-matched bone marrow transplantation.” Transplant Proc 19, no. 1 Pt 3 (February 1987): 2700.Link to Item
-
Fefer, A., K. M. Sullivan, P. Weiden, C. D. Buckner, G. Schoch, R. Storb, and E. D. Thomas. “Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation.” Prog Clin Biol Res 244 (1987): 401–8.Link to Item
-
Lum, L. G., M. C. Seigneuret, S. Shiobara, J. Noges, N. Munn, N. Shough, N. R. Jin, P. Beatty, P. Martin, and K. Sullivan. “Adoptively transferred immunity persists in human marrow graft recipients.” Prog Clin Biol Res 244 (1987): 449–60.Link to Item
-
Sullivan, K. M., A. Fefer, R. Witherspoon, R. Storb, C. D. Buckner, P. Weiden, G. Schoch, and E. D. Thomas. “Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation.” Prog Clin Biol Res 244 (1987): 391–99.Link to Item
-
Deeg, H. J., K. M. Sullivan, C. D. Buckner, R. Storb, F. R. Appelbaum, R. A. Clift, K. Doney, J. E. Sanders, R. P. Witherspoon, and E. D. Thomas. “Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation.” Bone Marrow Transplant 1, no. 2 (December 1986): 151–57.Link to Item
-
Deeg, H. J., S. Self, R. Storb, K. Doney, F. R. Appelbaum, R. P. Witherspoon, K. M. Sullivan, K. Sheehan, J. Sanders, and E. Mickelson. “Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors.” Blood 68, no. 6 (December 1986): 1363–68.Link to Item
-
Sanders, J. E., S. Pritchard, P. Mahoney, D. Amos, C. D. Buckner, R. P. Witherspoon, H. J. Deeg, K. C. Doney, K. M. Sullivan, and F. R. Appelbaum. “Growth and development following marrow transplantation for leukemia.” Blood 68, no. 5 (November 1986): 1129–35.Link to Item
-
Ueda, M., T. Mori, S. Shiobara, M. Harada, T. Yoshida, T. Matsuda, K. Hattori, H. Mizoguchi, K. M. Sullivan, and R. P. Witherspoon. “Development of bullous pemphigoid after allogeneic bone marrow transplantation. Report of a case.” Transplantation 42, no. 3 (September 1986): 320–22. https://doi.org/10.1097/00007890-198609000-00022.Full Text Link to Item
-
Bolger, G. B., K. M. Sullivan, A. M. Spence, F. R. Appelbaum, R. Johnston, J. E. Sanders, H. J. Deeg, R. P. Witherspoon, K. C. Doney, and J. Nims. “Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease.” Neurology 36, no. 8 (August 1986): 1087–91. https://doi.org/10.1212/wnl.36.8.1087.Full Text Link to Item
-
Bolger, G. B., K. M. Sullivan, R. Storb, R. P. Witherspoon, P. L. Weiden, P. Stewart, J. Sanders, J. D. Meyers, P. J. Martin, and K. C. Doney. “Second marrow infusion for poor graft function after allogeneic marrow transplantation.” Bone Marrow Transplant 1, no. 1 (May 1986): 21–30.Link to Item
-
Deeg, H. J., L. G. Lum, J. Sanders, G. J. Levy, K. M. Sullivan, P. Beatty, E. D. Thomas, and R. Storb. “Severe aplastic anemia associated with chronic mucocutaneous candidiasis. Immunologic and hematologic reconstitution after allogeneic bone marrow transplantation.” Transplantation 41, no. 5 (May 1986): 583–86. https://doi.org/10.1097/00007890-198605000-00006.Full Text Link to Item
-
Sullivan, K. M., H. J. Deeg, J. Sanders, A. Klosterman, D. Amos, H. Shulman, G. Sale, P. Martin, R. Witherspoon, and F. Appelbaum. “Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation.” Blood 67, no. 4 (April 1986): 1172–75.Link to Item
-
Anasetti, C., K. C. Doney, R. Storb, J. D. Meyers, V. T. Farewell, C. D. Buckner, F. R. Appelbaum, K. M. Sullivan, R. A. Clift, and H. J. Deeg. “Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients.” Ann Intern Med 104, no. 4 (April 1986): 461–66. https://doi.org/10.7326/0003-4819-104-4-461.Full Text Link to Item
-
Storb, R., H. J. Deeg, J. Whitehead, F. Appelbaum, P. Beatty, W. Bensinger, C. D. Buckner, R. Clift, K. Doney, and V. Farewell. “Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.” N Engl J Med 314, no. 12 (March 20, 1986): 729–35. https://doi.org/10.1056/NEJM198603203141201.Full Text Link to Item
-
Klingemann, H. G., R. Storb, A. Fefer, H. J. Deeg, F. R. Appelbaum, C. D. Buckner, M. A. Cheever, P. D. Greenberg, P. S. Stewart, and K. M. Sullivan. “Bone marrow transplantation in patients aged 45 years and older.” Blood 67, no. 3 (March 1986): 770–76.Link to Item
-
McDonald, G. B., H. M. Shulman, K. M. Sullivan, and G. D. Spencer. “Intestinal and hepatic complications of human bone marrow transplantation. Part II.” Gastroenterology 90, no. 3 (March 1986): 770–84. https://doi.org/10.1016/0016-5085(86)91137-6.Full Text Link to Item
-
McDonald, G. B., H. M. Shulman, K. M. Sullivan, and G. D. Spencer. “Intestinal and hepatic complications of human bone marrow transplantation. Part I.” Gastroenterology 90, no. 2 (February 1986): 460–77. https://doi.org/10.1016/0016-5085(86)90949-2.Full Text Link to Item
-
Deeg, H. J., K. Doney, and K. M. Sullivan. “Antithymocyte globulin followed by cyclosporine for the treatment of acute GVHD in patients given HLA-identical or -nonidentical marrow grafts.” Transplantation Proceedings 18, no. 4 (January 1, 1986): 791–93.
-
Sullivan, K. M. “Acute and chronic graft-versus-host disease in man.” International Journal of Cell Cloning 4, no. SUPPL. 1 (1986): 42–93.
-
Sullivan, K. M. “Acute and chronic graft-versus-host disease in man.” Int J Cell Cloning 4 Suppl 1 (1986): 42–93. https://doi.org/10.1002/stem.5530040710.Full Text Link to Item
-
Sullivan, K. M., F. R. Appelbaum, S. J. Horning, S. A. Rosenberg, and E. D. Thomas. “Selection of patients with Hodgkin's disease and non-Hodgkin's lymphoma for bone marrow transplantation.” Int J Cell Cloning 4 Suppl 1 (1986): 94–106. https://doi.org/10.1002/stem.5530040711.Full Text Link to Item
-
Sullivan, K. M., J. D. Meyers, N. Flournoy, R. Storb, and E. D. Thomas. “Early and late interstitial pneumonia following human bone marrow transplantation.” Int J Cell Cloning 4 Suppl 1 (1986): 107–21. https://doi.org/10.1002/stem.5530040712.Full Text Link to Item
-
Locksley, R. M., N. Flournoy, K. M. Sullivan, and J. D. Meyers. “Infection with varicella-zoster virus after marrow transplantation.” J Infect Dis 152, no. 6 (December 1985): 1172–81. https://doi.org/10.1093/infdis/152.6.1172.Full Text Link to Item
-
Appelbaum, F. R., K. M. Sullivan, E. D. Thomas, C. D. Buckner, R. A. Clift, H. J. Deeg, P. E. Neiman, J. E. Sanders, P. Stewart, and R. Storb. “Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease.” J Clin Oncol 3, no. 11 (November 1985): 1490–94. https://doi.org/10.1200/JCO.1985.3.11.1490.Full Text Link to Item
-
Deeg, H. J., T. P. Loughran, R. Storb, M. S. Kennedy, K. M. Sullivan, K. Doney, F. R. Appelbaum, and E. D. Thomas. “Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone.” Transplantation 40, no. 2 (August 1985): 162–66. https://doi.org/10.1097/00007890-198508000-00011.Full Text Link to Item
-
Sullivan, K. M., J. D. Meyers, and J. Clark. “Mycobacterial pulmonary infections after allogeneic bone marrow transplantation.” Am J Med 79, no. 1 (July 1985): A107–20.Link to Item
-
Kennedy, M. S., H. J. Deeg, R. Storb, K. Doney, K. M. Sullivan, R. P. Witherspoon, F. R. Appelbaum, P. Stewart, J. Sanders, and C. D. Buckner. “Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine.” Am J Med 78, no. 6 Pt 1 (June 1985): 978–83. https://doi.org/10.1016/0002-9343(85)90221-9.Full Text Link to Item
-
Izutsu, K. T., T. W. Menard, M. M. Schubert, W. Y. Ensign, K. Sullivan, E. L. Truelove, and E. D. Thomas. “Graft versus host disease-related secretory immunoglobulin A deficiency in bone marrow transplant recipients. Findings in labial saliva.” Lab Invest 52, no. 3 (March 1985): 292–97.Link to Item
-
Irle, C., H. J. Deeg, C. D. Buckner, M. Kennedy, R. Clift, R. Storb, F. R. Appelbaum, P. Beatty, W. Bensinger, and K. Doney. “Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine.” Leuk Res 9, no. 10 (1985): 1255–61. https://doi.org/10.1016/0145-2126(85)90153-5.Full Text Link to Item
-
Sanders, J. E., N. Flournoy, E. D. Thomas, C. D. Buckner, L. G. Lum, R. A. Clift, F. R. Appelbaum, K. M. Sullivan, P. Stewart, and H. J. Deeg. “Marrow transplant experience in children with acute lymphoblastic leukemia: an analysis of factors associated with survival, relapse, and graft-versus-host disease.” Med Pediatr Oncol 13, no. 4 (1985): 165–72. https://doi.org/10.1002/mpo.2950130402.Full Text Link to Item
-
Thompson, C. B., C. H. June, K. M. Sullivan, and E. D. Thomas. “Association between cyclosporin neurotoxicity and hypomagnesaemia.” Lancet 2, no. 8412 (November 17, 1984): 1116–20. https://doi.org/10.1016/s0140-6736(84)91556-3.Full Text Link to Item
-
Witherspoon, R. P., R. Storb, H. Shulman, C. D. Buckner, H. J. Deeg, R. A. Clift, J. E. Sanders, K. Doney, G. McDonald, and K. M. Sullivan. “Marrow transplantation in hepatitis-associated aplastic anemia.” Am J Hematol 17, no. 3 (October 1984): 269–78. https://doi.org/10.1002/ajh.2830170307.Full Text Link to Item
-
Buckner, C. D., R. A. Clift, J. E. Sanders, P. Stewart, W. I. Bensinger, K. C. Doney, K. M. Sullivan, R. P. Witherspoon, H. J. Deeg, and F. R. Appelbaum. “Marrow harvesting from normal donors.” Blood 64, no. 3 (September 1984): 630–34.Link to Item
-
Schubert, M. M., K. M. Sullivan, T. H. Morton, K. T. Izutsu, D. E. Peterson, N. Flournoy, E. L. Truelove, G. E. Sale, C. D. Buckner, and R. Storb. “Oral manifestations of chronic graft-v-host disease.” Arch Intern Med 144, no. 8 (August 1984): 1591–95.Link to Item
-
Deeg, H. J., N. Flournoy, K. M. Sullivan, K. Sheehan, C. D. Buckner, J. E. Sanders, R. Storb, R. P. Witherspoon, and E. D. Thomas. “Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation.” Int J Radiat Oncol Biol Phys 10, no. 7 (July 1984): 957–64. https://doi.org/10.1016/0360-3016(84)90163-9.Full Text Link to Item
-
Ralph, D. D., S. C. Springmeyer, K. M. Sullivan, R. C. Hackman, R. Storb, and E. D. Thomas. “Rapidly progressive air-flow obstruction in marrow transplant recipients. Possible association between obliterative bronchiolitis and chronic graft-versus-host disease.” Am Rev Respir Dis 129, no. 4 (April 1984): 641–44.Link to Item
-
Navari, R. M., C. D. Buckner, R. A. Clift, R. Storb, J. E. Sanders, P. Stewart, K. M. Sullivan, B. Williams, G. W. Counts, and J. D. Meyers. “Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants.” Am J Med 76, no. 4 (April 1984): 564–72. https://doi.org/10.1016/0002-9343(84)90274-2.Full Text Link to Item
-
McDonald, G. B., K. M. Sullivan, and T. F. Plumley. “Radiographic features of esophageal involvement in chronic graft-vs.-host disease.” Ajr Am J Roentgenol 142, no. 3 (March 1984): 501–6. https://doi.org/10.2214/ajr.142.3.501.Full Text Link to Item
-
Witherspoon, R. P., D. Matthews, R. Storb, K. Atkinson, M. Cheever, H. J. Deeg, K. Doney, J. Kalbfleisch, D. Noel, and R. Prentice. “Recovery of in vivo cellular immunity after human marrow grafting. Influence of time postgrafting and acute graft-versus-host disease.” Transplantation 37, no. 2 (February 1984): 145–50. https://doi.org/10.1097/00007890-198402000-00006.Full Text Link to Item
-
Remlinger, K., P. J. Martin, J. A. Hansen, K. C. Doney, A. Smith, H. J. Deeg, K. Sullivan, R. Storb, and E. D. Thomas. “Murine monoclonal anti-T cell antibodies for treatment of steroid-resistant acute graft-versus-host disease.” Hum Immunol 9, no. 1 (January 1984): 21–35. https://doi.org/10.1016/0198-8859(84)90004-1.Full Text Link to Item
-
Storb, R., E. D. Thomas, C. D. Buckner, F. R. Appelbaum, R. A. Clift, H. J. Deeg, K. Doney, J. A. Hansen, R. L. Prentice, and J. E. Sanders. “Marrow transplantation for aplastic anemia.” Semin Hematol 21, no. 1 (January 1984): 27–35.Link to Item
-
Sullivan, K. M., H. J. Deeg, J. E. Sanders, H. M. Shulman, R. P. Witherspoon, K. Doney, F. R. Appelbaum, M. M. Schubert, P. Stewart, and S. Springmeyer. “Late complications after marrow transplantation.” Semin Hematol 21, no. 1 (January 1984): 53–63.Link to Item
-
Sullivan, K. M., and R. Storb. “Allogeneic marrow transplantation.” Cancer Invest 2, no. 1 (1984): 27–38. https://doi.org/10.3109/07357908409020284.Full Text Link to Item
-
Thompson, C. B., C. H. June, K. M. Sullivan, and E. D. Thomas. “Association between cyclosporin neurotoxicity and hypomagnesaemia.” Lancet 2, no. 8412 (1984): 1116–20.
-
Storb, R., R. L. Prentice, E. D. Thomas, F. R. Appelbaum, H. J. Deeg, K. Doney, A. Fefer, B. W. Goodell, E. Mickelson, and P. Stewart. “Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia.” Br J Haematol 55, no. 4 (December 1983): 573–85. https://doi.org/10.1111/j.1365-2141.1983.tb02839.x.Full Text Link to Item
-
Navari, R. M., K. M. Sullivan, S. C. Springmeyer, M. S. Siegel, J. D. Meyers, C. D. Buckner, J. E. Sanders, P. S. Stewart, R. A. Clift, and A. Fefer. “Mycobacterial infections in marrow transplant patients.” Transplantation 36, no. 5 (November 1983): 509–13. https://doi.org/10.1097/00007890-198311000-00008.Full Text Link to Item
-
Sullivan, K. M., and R. Parkman. “The pathophysiology and treatment of graft-versus-host disease.” Clin Haematol 12, no. 3 (October 1983): 775–89. https://doi.org/10.1016/s0308-2261(83)80010-1.Full Text Link to Item
-
Meyers, J. D., L. M. Day, L. G. Lum, and K. M. Sullivan. “Recombinant leukocyte A interferon for the treatment of serious viral infections after marrow transplant: a phase I study.” J Infect Dis 148, no. 3 (September 1983): 551–56. https://doi.org/10.1093/infdis/148.3.551.Full Text Link to Item
-
Sanders, J. E., C. D. Buckner, J. M. Leonard, K. M. Sullivan, R. P. Witherspoon, H. J. Deeg, R. Storb, and E. D. Thomas. “Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation.” Transplantation 36, no. 3 (September 1983): 252–55. https://doi.org/10.1097/00007890-198309000-00005.Full Text Link to Item
-
Jack, M. K., G. M. Jack, G. E. Sale, H. M. Shulman, and K. M. Sullivan. “Ocular manifestations of graft-v-host disease.” Arch Ophthalmol 101, no. 7 (July 1983): 1080–84. https://doi.org/10.1001/archopht.1983.01040020082014.Full Text Link to Item
-
Sullivan, K. M., P. E. Neiman, M. E. Kadin, S. Dahlberg, V. T. Farewell, R. H. Rudolph, C. M. Bagley, F. R. Appelbaum, and E. D. Thomas. “Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patients.” Blood 62, no. 1 (July 1983): 51–61.Link to Item
-
Appelbaum, F. R., R. A. Clift, C. D. Buckner, P. Stewart, R. Storb, K. M. Sullivan, and E. D. Thomas. “Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse.” Blood 61, no. 5 (May 1983): 949–53.Link to Item
-
Deeg, H. J., R. Storb, E. D. Thomas, F. Appelbaum, C. D. Buckner, R. A. Clift, K. Doney, et al. “Fanconi's anemia treated by allogeneic marrow transplantation.” Blood 61, no. 5 (May 1983): 954–59.Link to Item
-
Izutsu, K. T., K. M. Sullivan, M. M. Schubert, E. L. Truelove, H. M. Shulman, G. E. Sale, T. H. Morton, et al. “Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host disease.” Transplantation 35, no. 5 (May 1983): 441–46. https://doi.org/10.1097/00007890-198305000-00010.Full Text Link to Item
-
Storb, R., R. L. Prentice, K. M. Sullivan, H. M. Shulman, H. J. Deeg, K. C. Doney, C. D. Buckner, et al. “Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings.” Ann Intern Med 98, no. 4 (April 1983): 461–66. https://doi.org/10.7326/0003-4819-98-4-461.Full Text Link to Item
-
Storb, R., R. L. Prentice, M. Banaji, R. P. Witherspoon, K. M. Sullivan, P. Stewart, J. E. Sanders, et al. “Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?” Blood 61, no. 4 (April 1983): 672–75.Link to Item
-
Storb, R., R. L. Prentice, C. D. Buckner, R. A. Clift, F. Appelbaum, J. Deeg, K. Doney, et al. “Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment.” N Engl J Med 308, no. 6 (February 10, 1983): 302–7. https://doi.org/10.1056/NEJM198302103080602.Full Text Link to Item
-
Deeg, H. J., and K. M. Sullivan. “Chimeras - no longer a myth.” Immunology Today 4, no. 6 (January 1, 1983): 155–56. https://doi.org/10.1016/0167-5699(83)90001-4.Full Text
-
Izutsu, K. T., M. M. Schubert, E. L. Truelove, H. M. Shulman, G. E. Sale, T. H. Morton, W. Y. Ensign, et al. “The predictive value of elevated labial saliva sodium concentration: its relation to labial gland pathology in bone marrow transplant recipients.” Hum Pathol 14, no. 1 (January 1983): 29–35. https://doi.org/10.1016/s0046-8177(83)80043-4.Full Text Link to Item
-
Appelbaum, F. R., E. D. Thomas, C. D. Buckner, R. A. Clift, H. J. Deeg, A. Fefer, P. E. Neiman, J. Sanders, P. Stewart, and R. Storb. “Treatment of non-Hodgkin's lymphoma with chemoradiotherapy and allogenic marrow transplantation.” Hematol Oncol 1, no. 2 (1983): 149–57. https://doi.org/10.1002/hon.2900010205.Full Text Link to Item
-
Corson, S. L., K. Sullivan, F. Batzer, C. August, R. Storb, and E. D. Thomas. “Gynecologic manifestations of chronic graft-versus-host disease.” Obstet Gynecol 60, no. 4 (October 1982): 488–92.Link to Item
-
Clift, R. A., C. D. Buckner, E. D. Thomas, K. Doney, A. Fefer, P. E. Neiman, J. Singer, et al. “Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation.” Lancet 2, no. 8299 (September 18, 1982): 621–23. https://doi.org/10.1016/s0140-6736(82)92735-0.Full Text Link to Item
-
Atkinson, K., V. Farewell, R. Storb, M. S. Tsoi, K. M. Sullivan, R. P. Witherspoon, A. Fefer, R. Clift, B. Goodell, and E. D. Thomas. “Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease.” Blood 60, no. 3 (September 1982): 714–20.Link to Item
-
Sullivan, K. M., R. Storb, H. M. Shulman, C. M. Shaw, A. Spence, C. Beckham, R. A. Clift, C. D. Buckner, P. Stewart, and E. D. Thomas. “Immediate and delayed neurotoxicity after mechlorethamine preparation for bone marrow transplantation.” Ann Intern Med 97, no. 2 (August 1982): 182–89. https://doi.org/10.7326/0003-4819-97-2-182.Full Text Link to Item
-
Thomas, E. D., C. D. Buckner, J. E. Sanders, T. Papayannopoulou, C. Borgna-Pignatti, P. De Stefano, K. M. Sullivan, R. A. Clift, and R. Storb. “Marrow transplantation for thalassaemia.” Lancet 2, no. 8292 (July 31, 1982): 227–29. https://doi.org/10.1016/s0140-6736(82)90319-1.Full Text Link to Item
-
Atkinson, K., G. S. Incefy, R. Storb, K. M. Sullivan, T. Iwata, M. Dardenne, H. D. Ochs, R. A. Good, and E. D. Thomas. “Low serum thymic hormone levels in patients with chronic graft-versus-host disease.” Blood 59, no. 5 (May 1982): 1073–77.Link to Item
-
Atkinson, K., R. Storb, H. D. Ochs, S. Goehle, K. M. Sullivan, R. P. Witherspoon, L. G. Lum, et al. “Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humans.” Transplantation 33, no. 2 (February 1982): 168–73. https://doi.org/10.1097/00007890-198202000-00012.Full Text Link to Item
-
Storb, R., K. C. Doney, E. D. Thomas, F. Appelbaum, C. D. Buckner, R. A. Clift, H. J. Deeg, et al. “Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients.” Blood 59, no. 2 (February 1982): 236–46.Link to Item
-
Witherspoon, R. P., K. Kopecky, R. F. Storb, N. Flournoy, K. M. Sullivan, R. Sosa, H. J. Deeg, et al. “Immunological recovery in 48 patients following syngeneic marrow transplantation or hematological malignancy.” Transplantation 33, no. 2 (February 1982): 143–49. https://doi.org/10.1097/00007890-198202000-00008.Full Text Link to Item
-
Buckner, C. D., R. A. Clift, E. D. Thomas, J. E. Sanders, R. Hackman, P. S. Stewart, R. Storb, and K. M. Sullivan. “Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission.” Leuk Res 6, no. 3 (1982): 395–99. https://doi.org/10.1016/0145-2126(82)90103-5.Full Text Link to Item
-
Badger, C., C. D. Buckner, E. D. Thomas, R. A. Clift, J. E. Sanders, P. S. Stewart, R. Storb, K. M. Sullivan, H. Shulman, and N. Flournoy. “Allogeneic marrow transplantation for acute leukemia in relapse.” Leuk Res 6, no. 3 (1982): 383–87. https://doi.org/10.1016/0145-2126(82)90101-1.Full Text Link to Item
-
Buckner, C. D., R. A. Clift, E. D. Thomas, J. E. Sanders, P. S. Stewart, R. Storb, K. M. Sullivan, and R. Hackman. “Allogeneic marrow transplantation for acute non-lymphoblastic leukemia in relapse using fractionated total body irradiation.” Leuk Res 6, no. 3 (1982): 389–94. https://doi.org/10.1016/0145-2126(82)90102-3.Full Text Link to Item
-
Clift, R. A., C. D. Buckner, E. D. Thomas, J. E. Sanders, P. S. Stewart, K. M. Sullivan, R. McGuffin, J. Hersman, G. E. Sale, and R. Storb. “Allogeneic marrow transplantation using fractionated total body irradiation in patients with acute lymphoblastic leukemia in relapse.” Leuk Res 6, no. 3 (1982): 401–7. https://doi.org/10.1016/0145-2126(82)90104-7.Full Text Link to Item
-
Clift, R. A., C. D. Buckner, E. D. Thomas, J. E. Sanders, P. S. Stewart, R. McGuffin, J. Hersman, K. M. Sullivan, G. E. Sale, and R. Storb. “Allogeneic marrow transplantation for acute lymphoblastic leukemia in remission using fractionated total body irradiation.” Leuk Res 6, no. 3 (1982): 409–12. https://doi.org/10.1016/0145-2126(82)90105-9.Full Text Link to Item
-
Sale, G. E., H. M. Shulman, M. M. Schubert, K. M. Sullivan, K. J. Kopecky, R. C. Hackman, T. H. Morton, R. Storb, and E. D. Thomas. “Oral and ophthalmic pathology of graft versus host disease in man: predictive value of the lip biopsy.” Hum Pathol 12, no. 11 (November 1981): 1022–30. https://doi.org/10.1016/s0046-8177(81)80260-2.Full Text Link to Item
-
Storb, R., M. S. Tsoi, R. P. Witherspoon, K. Sullivan, L. Lum, H. J. Deeg, and K. Atkinson. “Unique immunologic problems in human bone marrow transplant recipients.” Transplant Proc 13, no. 3 (September 1981): 1624–27.Link to Item
-
Witherspoon, R. P., R. Storb, H. D. Ochs, N. Fluornoy, K. J. Kopecky, K. M. Sullivan, J. H. Deeg, et al. “Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment.” Blood 58, no. 2 (August 1981): 360–68.Link to Item
-
Weiden, P. L., K. M. Sullivan, N. Flournoy, R. Storb, E. D. Thomas, and E. D. Seattle Marrow Transplant Team. “Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.” N Engl J Med 304, no. 25 (June 18, 1981): 1529–33. https://doi.org/10.1056/NEJM198106183042507.Full Text Link to Item
-
McDonald, G. B., K. M. Sullivan, M. D. Schuffler, H. M. Shulman, and E. D. Thomas. “Esophageal abnormalities in chronic graft-versus-host disease in humans.” Gastroenterology 80, no. 5 pt 1 (May 1981): 914–21.Link to Item
-
Weiden, P. L., N. Flournoy, J. E. Sanders, K. M. Sullivan, and E. D. Thomas. “Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation.” Transplant Proc 13, no. 1 Pt 1 (March 1981): 248–51.Link to Item
-
Sullivan, K. M., H. M. Shulman, R. Storb, P. L. Weiden, R. P. Witherspoon, G. B. McDonald, M. M. Schubert, K. Atkinson, and E. D. Thomas. “Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.” Blood 57, no. 2 (February 1981): 267–76.Link to Item
-
Shulman, H. M., K. M. Sullivan, P. L. Weiden, G. B. McDonald, G. E. Striker, G. E. Sale, R. Hackman, M. S. Tsoi, R. Storb, and E. D. Thomas. “Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.” Am J Med 69, no. 2 (August 1980): 204–17. https://doi.org/10.1016/0002-9343(80)90380-0.Full Text Link to Item
-
Atkinson, K., R. Storb, R. L. Prentice, P. L. Weiden, R. P. Witherspoon, K. Sullivan, D. Noel, and E. D. Thomas. “Analysis of late infections in 89 long-term survivors of bone marrow transplantation.” Blood 53, no. 4 (April 1979): 720–31.Link to Item
-
Harrison, D. T., P. E. Neiman, K. Sullivan, M. Hafermann, R. H. Rudolph, and A. B. Einstein. “Combined modality therapy for advanced, diffuse lymphocytic and histiocytic lymphomas.” Cancer 42, no. 4 (October 1978): 1697–1704. https://doi.org/10.1002/1097-0142(197810)42:4<1697::aid-cncr2820420407>3.0.co;2-g.Full Text Link to Item
-
Petersen, D. L., L. D. Hudson, and K. Sullivan. “Disseminated Nocardia caviae with positive blood cultures.” Arch Intern Med 138, no. 7 (July 1978): 1164–65.Link to Item
-
Shulman, H. M., G. E. Sale, K. G. Lerner, E. A. Barker, P. L. Weiden, K. Sullivan, B. Gallucci, E. D. Thomas, and R. Storb. “Chronic cutaneous graft-versus-host disease in man.” Am J Pathol 91, no. 3 (June 1978): 545–70.Link to Item
-
-
Book Sections
-
Tyndall, A. G., and K. M. Sullivan. “Cell-based therapies.” In Scleroderma: From Pathogenesis to Comprehensive Management, 591–602, 2012. https://doi.org/10.1007/978-1-4419-5774-0_49.Full Text
-
Kansu, E., and K. M. Sullivan. “Late complications of hematopoietic stem cell transplantation.” In Hematopoietic Stem Cell Transplantation, 413–33, 2000.
-
-
Conference Papers
-
Winthrop, K., F. A. Farraye, K. M. Sullivan, D. O. Willer, P. Vink, and F. Tavares-Da-Silva. “AB1072 HERPES ZOSTER IN INDIVIDUALS WITH AUTOIMMUNE DISEASES AND RECOMBINANT HERPES ZOSTER VACCINE AS A PREVENTATIVE STRATEGY.” In Annals of the Rheumatic Diseases, 81:1655.2-1656. BMJ, 2022. https://doi.org/10.1136/annrheumdis-2022-eular.1806.Full Text
-
Smith, Patrick J., Meagan Lew, Yen Lowder, Kristi Romero, Jillian C. Thompson, Lauren Bohannon, Alyssa Pittman, et al. “Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation.” In Bone Marrow Transplant, 57:89–94, 2022. https://doi.org/10.1038/s41409-021-01470-z.Full Text Link to Item
-
Maung, Ko, Nelson Jen An Chao, Kelly Corbet, Ashley Morris Engemann, Cristina Gasparetto, Mitchell Horwitz, Yubin Kang, et al. “CLO20-049: Retrospective Study of Safety and Toxicity Profile Comparison for Propylene Glycol-Free Melphalan (Evomela®) and Generic Melphalan.” In Journal of the National Comprehensive Cancer Network, 18:CLO20-049. Harborside Press, LLC, 2020. https://doi.org/10.6004/jnccn.2019.7412.Full Text
-
Anand, Sarah, Samantha Thomas, Kelly Corbet, Cristina Gasparetto, Gwynn D. Long, Richard Lopez, Ashley K. Morris, et al. “Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning.” In Biol Blood Marrow Transplant, 23:1949–54, 2017. https://doi.org/10.1016/j.bbmt.2017.06.027.Full Text Link to Item
-
Anand, Sarah, Samantha Thomas, Kelly Corbet, Cristina Gasparetto, Richard Lopez, Gwynn D. Long, Ashley K. Morris, et al. “Adult Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation, Fludarabine, and Thiotepa Conditioning.” In Blood, 128:3395–3395. American Society of Hematology, 2016. https://doi.org/10.1182/blood.v128.22.3395.3395.Full Text
-
Krishnamurti, Lakshmanan, Keith M. Sullivan, Naynesh R. Kamani, Edmund K. Waller, Allistair Abraham, Federico Campigotto, Wandi Zhang, et al. “Results of a Multicenter Pilot Investigation of Bone Marrow Transplantation in Adults with Sickle Cell Disease (STRIDE).” In Blood, 126:543–543. American Society of Hematology, 2015. https://doi.org/10.1182/blood.v126.23.543.543.Full Text
-
Kanda, J., L. Kaynar, Y. Kanda, V. K. Prasad, S. H. Parikh, D. A. Rizzieri, G. D. Long, et al. “Use of Cyclosporine Is Associated with the Increase in Pre-Engraftment Syndrome After Myeloablative Dual Cord Blood Transplantation.” In Biology of Blood and Marrow Transplantation, 18:S332–S332. Elsevier BV, 2012. https://doi.org/10.1016/j.bbmt.2011.12.336.Full Text
-
Bacon, Wendi A., Gwynn D. Long, David A. Rizzieri, Mitchell E. Horwitz, John P. Chute, Keith M. Sullivan, Amanda Yopp, Angela Johns, Nelson J. Chao, and Cristina Gasparetto. “Impact of High Dose Cyclophosphamide on the Outcome of Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma.” In Blood, 118:1765–1765. AMER SOC HEMATOLOGY, 2011.Link to Item
-
Gasparetto, Cristina, Wendi A. Bacon, Phuong Doan, David A. Rizzieri, Mitchell E. Horwitz, John P. Chute, Keith M. Sullivan, et al. “High Dose BCNU/Melphalan Preparative Regimen Doubles Event Free Survival of Myeloma Patients Undergoing Autologous Transplantation.” In Blood, 118:879–879. AMER SOC HEMATOLOGY, 2011.Link to Item
-
Kanda, Junya, David A. Rizzieri, Gwynn D. Long, Cristina Gasparetto, John P. Chute, Keith M. Sullivan, Ashley Morris, et al. “The Impact of Lymphocyte Subset Recovery At 3 Months on Progression-Free Survival After Myeloablative Allogeneic Stem Cell Transplantation.” In Blood, 118:1736–1736. AMER SOC HEMATOLOGY, 2011.Link to Item
-
Kanda, J., M. E. Horwitz, G. D. Long, C. Gasparetto, K. M. Sullivan, J. P. Chute, A. Morris, T. Hennig, N. J. Chao, and D. A. Rizzieri. “Outcomes of a 1-Day Nonmyeloablative Preparative Regimen for Primary Graft Failure After Allogeneic Stem Cell Transplantation.” In Biology of Blood and Marrow Transplantation, 17:S308–S308. Elsevier BV, 2011. https://doi.org/10.1016/j.bbmt.2010.12.460.Full Text
-
Sullivan, K. M., D. B. Froshaug, D. E. Furst, R. A. Nash, M. D. Mayes, L. J. Crofford, P. A. McSweeney, E. A. Goldmuntz, L. Keyes-Elstein, and D. Khanna. “Organ Function and Quality of Life Correlates at Randomization on the Scot (Scleroderma: Cyclophosphamide or Transplantation) Trial.” In Biology of Blood and Marrow Transplantation, 17:S195–S195. Elsevier BV, 2011. https://doi.org/10.1016/j.bbmt.2010.12.134.Full Text
-
Kanda, Junya, Gwynn D. Long, Cristina Gasparetto, Mitchell E. Horwitz, Keith M. Sullivan, John P. Chute, Ashley Morris, Zhiguo Li, Nelson J. Chao, and David A. Rizzieri. “Prospective, Biological Randomized Study of T-Cell Depleted Nonmyeloablative Allogeneic Transplantation From HLA-Matched Related, Unrelated or Haploidentical Donors for Patients with Hematologic Malignancies.” In Blood, 116:1456–57. AMER SOC HEMATOLOGY, 2010.Link to Item
-
Doan, P. L., J. P. Chute, C. Gasparetto, M. Horwitz, D. Rizzieri, C. Smith, K. Sullivan, et al. “Long Term Survival Following High-dose Sequential Therapy with Autologous Hematopoietic Cell Rescue for Multiple Myeloma,” 16:S201–S201, 2010.
-
Pergam, S. A., S. I. Strasser, M. E. Flowers, K. M. Sullivan, and G. B. McDonald. “78: Chronic Hepatitis C, Cirrhosis, and End Stage Liver Disease Among 30-Year Survivors of Bone Marrow Transplant.” In Biology of Blood and Marrow Transplantation, 14:31–31. Elsevier BV, 2008. https://doi.org/10.1016/j.bbmt.2007.12.086.Full Text
-
Craciunescu, O., B. Steffey, S. Yoo, N. Larrier, C. Paarz‐largay, K. Sullivan, and R. Prosnitz. “TU‐EE‐A2‐05: Challenges in Limiting Kidney Dose When Delivering Total Body Irradiation (TBI) for Patients with Severe Systemic Sclerosis (SSc).” In Medical Physics, 34:2568, 2007. https://doi.org/10.1118/1.2761426.Full Text
-
Nash, Richard A., Peter A. McSweeney, Leslie J. Crofford, Kevin T. McDonagh, Keith M. Sullivan, Mayes Maureen, J Lee Nelson, et al. “5-year follow-up of high-dose immunosuppressive therapy (HDIT) for systemic sclerosis (SSc).” In Arthritis and Rheumatism, 54:S315–S315. WILEY-LISS, 2006.Link to Item
-
Rizzieri, D. A., L. P. Koh, G. D. Long, C. Gasparetto, K. M. Sullivan, M. Horwitz, J. Chute, et al. “Partially HLA matched, non-myeloablative allogeneic transplantation.” In Blood, 106:812A-812A. AMER SOC HEMATOLOGY, 2005.Link to Item
-
Rizzieri, David A., Liang Piu Koh, Gwynn D. Long, Cristina Gasparetto, Jerald Z. Gong, Anand S. Lagoo, Donna Niedzwiecki, et al. “Outcome and Immune Reconstitution Following T Cell Depleted Nonmyeloablative Allogeneic Transplantation Using Matched Donors.” In Blood, 106:2036–2036. American Society of Hematology, 2005. https://doi.org/10.1182/blood.v106.11.2036.2036.Full Text
-
Walters, Mark C., Melinda Patience, Sandie Edwards, Shanda Robertson, Marsha McMurray, Sharyne Donfield, and Keith M. Sullivan. “Hematopoietic Cell Transplantation for Sickle Cell Disease: Updated Results of the Multicenter Trial.” In Blood, 104:104–104. American Society of Hematology, 2004. https://doi.org/10.1182/blood.v104.11.104.104.Full Text
-
Furst, D. E., P. A. McSweeney, L. J. Crofford, K. T. McDonagh, K. M. Sullivan, M. D. Mayes, J. L. Nelson, et al. “High-Dose Immunosuppressive Therapy (HDIT) for SSc: Results of 3 year follow-up demonstrate continued improvement in function and skin with stability in the lungs.” In Arthritis and Rheumatism, 50:S693–S693. WILEY-LISS, 2004.Link to Item
-
Woodard, J. P., J. M. Cunningham, K. M. Sullivan, N. R. Kamani, and M. C. Walters. “Bronchiolitis obliterans organizing pneumonia (BOOP) after bone marrow transplantation (BMT) for sickle cell disease (SCD): Association with acute chest syndrome (ACS).” In Blood, 102:460B-461B. AMER SOC HEMATOLOGY, 2003.Link to Item
-
Iannone, R., J. F. Casella, E. J. Fuchs, A. R. Chen, A. Woolfrey, M. Amylon, K. M. Sullivan, R. F. Storb, and M. C. Walters. “Failure of a minimally toxic non-myeloablative regimen to establish stable donor engraftment after transplantation for sickle cell anemia and beta-thalassemia.” In Blood, 100:46A-46A. AMER SOC HEMATOLOGY, 2002.Link to Item
-
Nash, R. A., J. D. Bowen, P. A. McSweeney, K. M. Sullivan, Z. S. Pavletic, K. R. Maravilla, J. Al-Omaishi, et al. “Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT): 2 year follow-up.” In Blood, 100:864A-864A. AMER SOC HEMATOLOGY, 2002.Link to Item
-
Nash, R. A., P. A. McSweeney, R. Storb, K. M. Sullivan, A. Langston, J. L. Sunderhaus, M. Wener, and D. Furst. “Treatment of severe systemic sclerosis with allogenic marrow transplantation.” In Blood, 100:460B-461B. AMER SOC HEMATOLOGY, 2002.Link to Item
-
Walters, M. C., M. Patience, W. Leisenring, R. G. Steen, C. Zamani, E. Vichinsky, R. Storb, and K. M. Sullivan. “Updated results of bone marrow transplantation (BMT) for sickle cell disease (SCD): Impact on CNS disease.” In Blood, 100:45A-46A. AMER SOC HEMATOLOGY, 2002.Link to Item
-
Bichindaritz, I., E. Kansu, and K. M. Sullivan. “Case-based reasoning in care-partner: Gathering evidence for evidence-based medical practice.” In Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), 1488:334–45, 1998. https://doi.org/10.1007/BFb0056345.Full Text
-
-
- Scholarly, Clinical, & Service Activities
-
Service to the Profession
- Co-chair. Autoimmune Disease Working Group. International Bone Marrow Transplant Registry. 2001 - 2005 2001 - 2005
- Chair. Nominating Committee. American Society of Hematology. 2000 - 2002 2000 - 2002
- Board of Directors. Foundation for the Accreditation of Hematopoietic Cell Therapy. 1996 - 2000 1996 - 2000
- President. American Society for Blood and Marrow Transplantation. 1995 - 1996 1995 - 1996
- Executive Committee and Secretary. American Society of Hematology. 1994 - 2000 1994 - 2000
- Vice President. American Society for Blood and Marrow Transplantation. 1993 - 1994 1993 - 1994
- Founding Chair. Scientific Subcommittee on Transplantation Biology. American Society of Hematology. 1992 - 1993 1992 - 1993
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.